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Abstract 
 Shiga toxin-producing Escherichia coli serogroups (O26, O45, O103, O111, O121, 
O145, and O157; STEC-7) are recognized as major food-borne pathogens with outbreaks, human 
infections, and occasional deaths associated with the consumption of contaminated foods.  Cattle 
are recognized as the primary reservoir for STEC-7 and shed these bacteria in their feces, which 
are considered a principal source of contamination of cattle hides and carcasses at harvest.  Pre-
harvest interventions that effectively reduce fecal shedding of STEC-7 have the potential to 
reduce the public health concerns and economic impact of these bacteria and enhance food 
safety.  In the research presented in this dissertation, distinct study designs were used to evaluate 
the impact of commercially available pre-harvest interventions and develop a better 
understanding of the epidemiology of STEC-7 in commercial feedlot cattle.  A randomized pen-
level trial indicated that a commercially available vaccine significantly reduced the fecal 
prevalence of STEC O157 and prevalence of high shedders compared to unvaccinated pens.  
However, there was no evidence of a direct-fed microbial (DFM) effect on either measure of 
STEC O157 shedding.  In a continuum of the efficacy study, the performance and carcass 
characteristics associated with these pre-harvest interventions were quantified.  Results indicated 
that feeding the DFM to cattle improved performance, whereas the vaccine negatively impacted 
performance during the intervention period, though most of these attributes were not reflected at 
the time the animals were harvested.  Later, a cross-sectional observational study was used to 
determine the regional-, feedlot- and pen-level fecal prevalence of enterohemorrhagic 
Escherichia coli (EHEC), a subset of STEC, in commercial feedlot cattle.  Results indicated that 
EHEC serogroup O157 was detected more frequently than non-O157 serogroups of EHEC; 
however, all feedlots had at least one sample positive for both O157 and non-O157 EHEC.  
  
Further, risk factors associated with non-O157 serogroups of EHEC were identified; further 
evaluation of these factors as potential control points may enable the ability to positively impact 
public health concerns and food safety by reducing the pathogen load prior to harvest.  Overall, 
the research described in this dissertation provides an assessment of pre-harvest interventions 
and multi-level prevalence estimates of STEC-7 in commercial feedlot operations.  
 
 
 
  
  
EPIDEMIOLOGY OF SHIGA TOXIN-PRODUCING ESCHERICHIA COLI IN 
COMMERICIAL FEEDLOT CATTLE  
 
 
by 
 
 
CHARLEY ABRAHAM CULL 
 
 
 
B.S., Kansas State University, 2012 
D.V.M., Kansas State University, 2014 
 
 
 
A DISSERTATION 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
 
 
DOCTOR OF PHILOSOPHY 
 
 
 
Department of Diagnostic Medicine/Pathobiology 
College of Veterinary Medicine 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2016 
 
 
 
 
Approved by: 
 
Major Professor 
David G. Renter 
  
  
Copyright 
Charley Abraham Cull 
2016 
  
  
Abstract 
Shiga toxin-producing Escherichia coli serogroups (O26, O45, O103, O111, O121, 
O145, and O157; STEC-7) are recognized as major food-borne pathogens with outbreaks, human 
infections, and occasional deaths associated with the consumption of contaminated foods.  Cattle 
are recognized as the primary reservoir for STEC-7 and shed these bacteria in their feces, which 
are considered a principal source of contamination of cattle hides and carcasses at harvest.  Pre-
harvest interventions that effectively reduce fecal shedding of STEC-7 have the potential to 
reduce the public health concerns and economic impact of these bacteria and enhance food 
safety.  In the research presented in this dissertation, distinct study designs were used to evaluate 
the impact of commercially available pre-harvest interventions and develop a better 
understanding of the epidemiology of STEC-7 in commercial feedlot cattle.  A randomized pen-
level trial indicated that a commercially available vaccine significantly reduced the fecal 
prevalence of STEC O157 and prevalence of high shedders compared to unvaccinated pens.  
However, there was no evidence of a direct-fed microbial (DFM) effect on either measure of 
STEC O157 shedding.  In a continuum of the efficacy study, the performance and carcass 
characteristics associated with these pre-harvest interventions were quantified.  Results indicated 
that feeding the DFM to cattle improved performance, whereas the vaccine negatively impacted 
performance during the intervention period, though most of these attributes were not reflected at 
the time the animals were harvested.  Later, a cross-sectional observational study was used to 
determine the regional-, feedlot- and pen-level fecal prevalence of enterohemorrhagic 
Escherichia coli (EHEC), a subset of STEC, in commercial feedlot cattle.  Results indicated that 
EHEC serogroup O157 was detected more frequently than non-O157 serogroups of EHEC; 
however, all feedlots had at least one sample positive for both O157 and non-O157 EHEC.  
  
Further, risk factors associated with non-O157 serogroups of EHEC were identified; further 
evaluation of these factors as potential control points may enable the ability to positively impact 
public health concerns and food safety by reducing the pathogen load prior to harvest.  Overall, 
the research described in this dissertation provides an assessment of pre-harvest interventions 
and multi-level prevalence estimates of STEC-7 in commercial feedlot operations.  
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Preface 
Although Shiga toxin-producing Escherichia coli serogroups (O26, O45, O103, O111, 
O121, O145, and O157; STEC-7) are major threats to public health and food safety, there are 
several pre-harvest interventions and epidemiologic aspects of STEC-7 in commercial feedlot 
cattle that are still unclear. To evaluate the impact of commercially available pre-harvest 
interventions and develop a better understanding of the epidemiology of STEC-7 in commercial 
feedlot cattle we used distinct study designs.  The studies describe in this dissertation provide an 
assessment of pre-harvest interventions and multi-level prevalence estimates of STEC-7 in 
commercial feedlot operations.   
My first study, was published in Vaccine and evaluated the effects of a commercially 
available STEC O157 vaccine and direct-fed microbial in commercial feedlot cattle.  My second 
study published, in the Journal of Animal Science, quantified the performance and carcass 
characteristics associated with these pre-harvest interventions.  My final study, was a cross-
sectional observational study that determined the feedlot- and pen-level fecal prevalence of 
enterohemorrhagic Escherichia coli (EHEC), a subset of STEC, in commercial feedlot cattle, as 
well as identified potential risk factors associated with non-O157 serogroups of EHEC.  Overall, 
the research described in this dissertation indicates the complex interrelationship among risk 
factors, targeted interventions, and microbial concentrations that must be considered in order to 
mitigate the transmission associated with STEC-7 in commercial feedlot cattle.      
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Chapter 1 - Literature Review on Shiga toxin-producing Escherichia 
coli and Commercial Feedlot Production 
 
 Introduction 
 Seven Shiga toxin-producing Escherichia coli (STEC) serogroups (STEC O26, O45, 
O103, O111, O121, O145, and O157; STEC-7) are recognized as major foodborne pathogens 
with outbreaks, human illnesses, and occasional deaths associated with the consumption of 
contaminated foods (USDA-FSIS, 2014; CDC, 2014).  Foodborne illnesses of STEC-7 have 
been linked to a variety of foods commodities in the United States (Scallan et al., 2011; Luna-
Gierke et al., 2014). However, ruminants, particularly cattle, are recognized as the primary 
reservoir of STEC, and intermittently shed these bacteria in their feces.  Subsequently, fecal 
contamination provides a unique opportunity for STEC-7 transfer with the potential for human 
exposure and contamination of food products by direct- or indirect-contact during harvest 
(Ferens and Hovde, 2011; Painter et al., 2013).  In addition to the major public health concerns, 
there has been a profound economic impact of STEC-7 on different food industries (NCBA, 
2012).  Pre-harvest interventions that effectively reduce fecal shedding of STEC-7 and cattle 
hide contamination may have the potential to reduce the public health concerns and economic 
impact of these bacteria and enhance food safety.  However, further defining the effects of pre-
harvest interventions on cattle performance and carcass characteristics are warranted due to 
potential financial implications for intervention adoption in the industry (Elam et al., 2004; 
Thomson et al., 2007). 
 Although E. coli O157:H7 (STEC O157) has been the primary serotype studied in human 
and animal populations for the past three decades, there is a growing body of scientific literature 
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regarding the epidemiology of non-O157 STEC (STEC O26, O45, O103, O111, O121, and 
O145)  in commercial feedlot operations (Callaway et al., 2009; Smith, 2014).  Recent reports 
have indicated several similarities in the epidemiologic approach of mitigating STEC O157 and 
non-O157 STEC; however, several differences remain in prevalence frequency, efficacy of pre-
harvest interventions, and available data to guide future research along the beef production 
system.  This scientific review on STEC-7 is limited to published studies that were performed at 
commercial feedlot operations in the United States.  Although pertinent information on the 
pathogenesis and epidemiology of STEC-7 will be discussed, specific biological information is 
only briefly mentioned.  Commercially available pre-harvest interventions will be discussed, 
with an emphasis on intervention efficacy and economic impacts in commercial feedlot 
operations.  This review of the ecology and epidemiology of STEC-7 in feedlot operations 
exposes critical data gaps, while providing an introduction for the studies described in 
subsequent chapters.  
 
 STEC in Human Foodborne Illness 
Shiga toxin-producing E. coli O157 and non-O157 STEC were first recognized as causes 
of human foodborne illnesses in 1982 and 2007, when outbreaks of hemorrhagic colitis were 
associated with the consumption of undercooked, contaminated ground beef in the United States 
(Riley et al., 1983; Wells et al., 1983; USDA-FSIS, 2014).  Data trends regarding the frequency 
of STEC-7 foodborne illnesses, since this time, indicate the importance of these pathogens as 
serious public health risks due to the frequency and severity of cases.  Shiga toxin-producing E. 
coli-7 are estimated to cause approximately 175,000 foodborne illnesses and 20 deaths each year 
in the United States (Scallan et al., 2011), while less than 40% of the STEC-7 foodborne illness 
3 
 
cases were associated with the consumption of contaminated ground beef or non-intact beef 
products (Withee et al., 2009).  In 2013, there were approximately 1.7 cases of STEC-7 per 
100,000 people (i.e. 1.15 cases of STEC O157 per 100,000 people and 1.18 cases of non-O157 
STEC per 100,000 people) in the United States (CDC, 2013), with the highest incidence 
occurring in children less than five years of age (4.2 cases per 100,000 people).  Further, the 
annual incidence of STEC-7 has decreased by 30% compared to initial surveillance data from 
1996 to 1998, yet there is no difference in incidence from 2006 to 2008 (CDC, 2013).  Although 
human STEC-7 illnesses are relatively uncommon compared to other foodborne pathogens (i.e. 
Campylobacter, Listeria, Salmonella, Shigella), the severity of STEC-7 infections justifies their 
classification as major foodborne pathogens (CDC, 2014). 
Although the clinical presentation and severity of STEC-7 infections may vary between 
human populations, life-threatening complications tend to occur in children (< 5 years old), 
elderly, and immunocompromised individuals (Griffin and Tauxe, 1991; CDC, 2014).  These 
complications are typically associated with hemorrhagic colitis (i.e. bloody diarrhea) and 
hemolytic-uremic syndrome (HUS), as 90% and 8% of all the STEC-7 infections in the United 
States lead to hemorrhagic colitis and HUS (CDC, 2014).  Hemolytic-uremic syndrome, a 
dangerous complication of STEC-7, is the most common cause of acute renal failure in children 
(Coia et al., 1998).  In 2012, the incidence of HUS in children less than 18 years of age was 0.56 
cases per 100,000 people, with the highest incidence (1.27 cases per 100,000 people) in children 
less than 5 years of age (Crim et al., 2014).  Recently, the overall incidence of HUS from STEC-
7 infections has decreased by 30% compare to surveillance data from 2006 to 2008 (Crim et al., 
2014), while the overall estimated case fatality rate is un-changed at 3 to 5% (Coia et al., 1998; 
CDC, 2010).  Although premature death rarely occurs among STEC-7 infected individuals (1 per 
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1000 cases), the economic impact of these cases account for approximately 95% of the total 
estimated human health-associated cost (i.e. $478 million) in the United States (Frenze et al., 
2005; USDA-ERS, 2011).  As a result, there has been an increase in industry and regulatory 
actions to improve pre- and post-harvest methods to prevent beef contamination, and other 
foodborne risks, due to the public health concerns and severity of STEC-7 foodborne illnesses. 
 
 Epidemiology of STEC in Cattle 
Although the body of scientific literature on STEC-7 pathogens was limited following the 
first reported foodborne outbreaks, pathogenic and non-pathogenic E. coli have been studies for 
decades.  Escherichia coli are commonly differentiated based on three surface antigens: capsular 
(K), flagellar (H), and somatic (O) (Gyles, 2007; Meng et al., 2007).  Although numerous E. coli 
serotypes are considered non-pathogenic (i.e. commensal bacteria in human and animal 
gastrointestinal tracts), the pathogenicity of diarrheagenic E. coli are further categorized into six 
major groups: enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive 
E. coli (EIEC), diffuse-adhering E. coli (DAEC), enteroaggregative E. coli (EAEC), and 
enterohemorrhagic E. coli (EHEC) (Kaper, 2004; Meng et al., 2007).  Shiga toxin-producing E. 
coli (STEC) belong to the diarrheagenic class known as EHEC; STEC are described by their 
ability to produce Shiga toxins (Moxley, 2004; Meng et al., 2007).  The potent cytotoxin, Shiga 
toxin, plays a key role in inducing vascular lesions and virulence for more than 200 pathogenic 
E. coli serotypes (Nataro and Kaper, 1998; Paton and Paton, 1998; Karmali et al., 2010; CDC, 
2014).  Of the pathogenic E. coli serotypes, STEC-7 foodborne pathogens have been linked to 
beef and are associated with human illnesses in the United States and elsewhere in the world 
(Bettelheim, 2007; Dambrosio et al., 2007; Cobbold et al., 2008; Ethelberg et al., 2009; CDC, 
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2014).  Consequently, these pathogens were declared adulterants in ground beef and non-intact 
beef products in the US (USDA-FSIS, 2014); this declaration provided the framework for 
additional STEC-7 research in beef production systems and public health.   
Shiga toxin-producing E. coli-7 have been discovered in many food commodities with 
the first known produce associated outbreak occurring in the early 1990s (Rangel et al., 2005).  
Human foodborne illness due to STEC-7 have been associated with a variety of produce, 
including leafy greens, vegetables, and fruits or nuts (Besser et al., 1993; Bilborn et al., 1999; 
Breuer et al., 2001; Rangel et al., 2005; Cobbold et al., 2008; Smith, 2014).  While other 
outbreaks have been associated with water sources, including drinking water, lake water, and 
ponds (Licence et al., 2001; CDC, 2014; Smith, 2014).  In addition, there are cattle-associated 
products which have been linked to raw milk, cheese, ground beef, and non-intact beef (Rangel 
et al., 2005; Cobbold et al., 2008; USDA-FSIS, 2014).  Although the public health risk for 
STEC-7 includes many food commodities and production systems, the pathway within 
commercial feedlot operations is the primary purpose for this review. 
The evidence to date suggests that ruminants, particularly cattle, are recognized as the 
primary reservoir of STEC-7 (CDC, 2014; USDA-FSIS, 2014).  Colonization of STEC occurs 
primarily in the distal rectum of cattle. Cattle are colonized by these bacteria primarily in the 
distal rectum (Nataro and Kaper, 1998; Kaper et al., 2004).  Although cattle are asymptomatic 
(i.e. does not result in clinical signs of illness) carriers of STEC-7, they intermediately shed these 
pathogens in their feces for different periods of time and at different concentrations (Low et al., 
2005; Cobbold et al., 2007; Cernicchiaro et al., 2014; CDC, 2014).  One study reported that 
approximately 65% of individual cattle shed for less than 30 days (Besser et al., 1997), while 
others indicated a potential relationship between the duration and concertation of fecal shedding 
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(Low et al., 2005; Cobbold et al., 2007; Chase-Topping et al., 2008).  Further, fecal shedding of 
STEC appears to vary based on O serogroup, with reports indicating a lower prevalence of non-
O157 STEC in non-intact beef products, raw ground beef, and cattle feces relative to STEC 
O157 (Renter et al., 2005; Renter et al., 2007; Bosilevac et al., 2007; Bosilevac and Koohmaraie, 
2011; Fratamico et al., 2011; Cernicchiaro et al., 2014).  More specifically, these studies 
indicated that STEC O157 was greater than 5 times more frequently detected than non-O157 
STEC.  However, the published literature has reported wide fecal prevalence estimates: ranging 
from 0.0 to < 20.0% for non-O157 STEC (Cernicchiaro et al., 2013 and 2014; Baltasar et al., 
2014; Ekiri et al., 2014; Paddock et al., 2014; Dewsbury et al., 2015) and 0.0 to 100.0% for 
STEC O157 (Dargatz et al., 1997; Laegreid et al., 1999; Elder et al., 2000; Smith et al., 2001; 
Reinstein et al., 2009).   
Furthermore, seasonality and geographic location are thought to affect fecal prevalence of 
STEC-7.  Recent studies have reported an increase of STEC-7 shedding in cattle feces during the 
summer months relative to the winter months (Chapman et al., 1997; Van Donkersgoed et al., 
2001; Renter et al., 2008; Dewsbury et al., 2015), while others have hypothesized potential 
prevalence differences when comparing commercial feedlot operations in southern states to 
northern states (Hancock et al., 1997; Callaway et al., 2009; Smith, 2014).  Although the exact 
reason for this phenomena is yet to be identified, a few studies have indicated that day length, 
pen condition, and temperature may effect fecal prevalence  of STEC-7 in cattle (Smith et al., 
2001; Sargeant et al., 2004; Edrington et al., 2006; Renter et al., 2007; Baltasar et al., 2014; Ekiri 
et al., 2014; Dewsbury et al., 2015).  While the majority of these studies have focused on STEC 
O157, additional prevalence estimates are required at different hierarchical levels to data gaps on 
non-O157 STEC and enable the building quantitative risk assessment models of STEC-7 along 
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the beef chain.  Further, the ability to correctly identify and managed other potential risk factors, 
such as cattle source, management, biosecurity, diet and cattle handling, against STEC-7 
shedding may enable positive impacts on food safety, as fecal shedding has been positively 
associated with hide and beef carcass contamination at harvest (Elder et al., 2002; Fox et al., 
2008; Jacob et al., 2010; Stromberg et al., 2015).  Some propose that cattle shedding higher 
concentrations of STEC-7 may pose a greater risk of hide and carcass contamination (Arthur et 
al., 2009; Smith, 2014; Stromberg et al., 2015).  Hence, studies of the effects of pre-harvest 
control strategies may need to be investigated for both prevalence and concentration of STEC-7 
in commercial feedlot cattle.  
 High shedders (i.e. super shedders) have been identified as cattle shedding at greater than 
104 CFU STEC-7/g of feces, while lower concentrations (<104 CFU STEC-7/g of feces) are 
often simply defined as fecal shedding (Chase-Topping et al., 2008).  Some reports propose that 
mitigation efforts should target high-shedding cattle since these animals contribute the highest 
potential  fecal load for hide and carcass contaminations at harvest (Loneragan and Brashears, 
2005; Matthews et al., 2006; Cobbold et al., 2007; Fox et al., 2008; Stephens et al., 2009).  As a 
result, additional research is required to determine the ecology and epidemiology of high 
shedders, as the proportion of high shedders within a cattle cohort may be important to reduce 
the risk of STEC-7 transfer and contamination (Matthews et al., 2006).  Regardless, high 
prevalence of STEC-7 in cattle feces at either concentration (i.e. fecal shedding or high shedders) 
is likely to contribute to the risk of contamination during slaughter (Loneragan and Brashears, 
2005). Thus, epidemiologic studies properly designed to identify the prevalence and fecal 
concertation of STEC-7 at different hierarchical levels in the beef production systems is 
extremely important to help guide future control efforts.   
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Although there are multiple factors effecting the transmission of STEC-7 within cohorts 
of cattle from the commercial feedlot operation to harvest, hides are the most likely imminent 
source of carcass contamination due to STEC-7 (Loneragan and Brashears, 2005; Woerner et al., 
2006).  Elder et al., (2002) indicated a significant correlations between hide prevalence and 
carcass contamination, while another report indicated a difference in hide prevalence of  STEC 
O157 when comparing pens with greater than 20% fecal prevalence versus less than 20% 
(Ransom et al., 2003).  In addition, research indicates that the prevalence of STEC-7 from 
sampling cattle upon entry into the plant to final product reduces at each step (e.g., hides, pre-
evisceration, post-evisceration, in-cooler samples); thus illustrating the effectiveness of post-
harvest intervention against STEC-7 (Elder et al., 2002; Stromberg et al., 2015).  However, 
additional animal- and pen-level data are required to accurately describe the entire relationship 
for prevalence and concertation of STEC-7 among fecal, hide, and carcass samples.  Yet, it is 
reasonable to hypothesize that reducing the STEC-7 fecal load prior to harvest should in turn 
reduce the likelihood of hide prevalence and subsequently carcass contamination at harvest 
(Loneragan and Brashears, 2005). 
 
 Pre-harvest Interventions 
Over the past three decades, the beef industry has focused a lot of time and resources on 
mitigating STEC-7 contamination at harvest by incorporating specific trainings procedures, 
programs (i.e. Hazard Analysis and Critical Control Points),  interventions, and diagnostic tests 
within packing plants.  Although effective, researchers have proposed that reducing the STEC-7 
fecal shedding load before harvest may increase the capabilities of post-harvest procedures 
(Callaway et al., 2004; Loneragan and Brashears 2005; Callaway et al., 2009; Smith 2014).   In 
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addition to reducing the fecal shedding of STEC-7 in cattle, pre-harvest interventions may have 
the potential to reduce the economic impact and public health concerns of these bacteria and 
enhance food safety (Hynes and Wachsmuth, 2000).  As a result, this opportunity has led to the 
development and research of many pre-harvest interventions (i.e. antibiotics, bacteriophages, 
diets, prebiotics, probiotics, and vaccines).  However, there are currently only two commercially 
available pre-harvest products (i.e. a vaccine and a direct-fed microbial) approved for reducing 
STEC O157 fecal shedding in the United States (Callaway et al., 2009; Smith 2014; Wisener et 
al., 2014).  
The use of antibiotics to specifically control fecal shedding of STEC in cattle is 
controversial.  However, reports have indicated that the use of neomycin, an aminoglycoside 
antibiotic, in the feed significantly reduces fecal shedding of STEC O157 in cattle (Elder et al., 
2002; Callaway et al., 2009).  Despite these findings, the beef industry has not adopted antibiotic 
treatment as a pre-harvest intervention strategy due to the potential concern of antimicrobial 
resistance (Loneragan and Brashears, 2005; Callaway et al., 2009).  In addition, a different class 
of feed grade antibiotics (i.e. ionophores) was tested for its effectiveness to reduce STEC O157 
shedding, as ionophores are not used in human medicine.  Although the issue of resistance may 
not be as critical with ionophores as with other antibiotics, research has indicated a lack of 
efficacy for ionophores against STEC O157 shedding in cattle feces (Edrington et al., 2006; 
Callaway et al., 2009).  However, ionophores are still approved and used for growth performance 
and coccidia control in commercial feedlot operations. 
Bacteriophages or phages, viruses that have the ability to specifically target certain 
organisms, use self-replication to adapt with bacteria and are reported to be harmless to animals 
(Sheng 2006; Sillankorva et al., 2012).  In vitro studies have indicated exceptional efficacy of 
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phages against STEC O157 (Tanji et al., 2005; Sheng et al., 2006), while initial in vivo studies 
indicated a reduction of STEC O157 when applying phages in drinking water or the recotanal 
junction (Sheng et al., 2006; Rozema et al., 2009).  However, other live animal studies have 
indicated mixed results, seemingly due to incorrect uses, doses, or strains of phages (Raya et al., 
2006; Sheng et al., 2006; Niu et al., 2008; Standford et al., 2010).  Still the unique ability to 
incorporate phages in production systems is intriguing due to the ease of administration (i.e. 
water, feed, spray), yet additional trials are required before incorporating phages in commercial 
feedlot operations (Rozema et al., 2009; Sillankorva et al., 2012).  However, phages are 
approved for commercial uses as a spray application to hides at packing plants.  
Scientists also have investigated sodium chlorate as a potential pre-harvest intervention 
(Loneragan and Brashears, 2005; Callaway et al., 2014).  Enterobacteriaceae (e.g. STEC -7) are 
facultative anaerobes that have the ability to use oxygen for aerobic respiration as well as 
anaerobic fermentation.  More specifically, STEC have the nitrate reductase enzyme that allows 
respiration and converts chlorate to a cytotoxic chlorite inside of STEC pathogens.  Therefore, 
the use of sodium chlorate may be considered a selective microbial product with the ability to 
target STEC-7 due to occurrence of the nitrate reductase enzyme.  Research has suggested that 
oral administration of sodium chlorate reduced STEC O157 shedding in cattle feces by more 
than two logs (Callaway et al., 2002; Anderson et al., 2005).  However, to date sodium chlorate 
is not commercially available as a pre-harvest intervention in commercial feedlot cattle, as 
additional data may need to be generated for approval.  
Scientists also have proposed that diets may be an important contributing factor to the 
gastrointestinal flora and pathogen populations of STEC in cattle (Fox et al., 2007; Jacob et al., 
2008; Reinstein et al., 2009).  Feeding cattle a high energy diet has been shown to positively 
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impact the STEC population in the lower gastrointestinal tract of cattle (Callaway et al., 2009).  
There have been mixed results regarding the impact of forage levels on STEC population, 
however, with some reports indicating a decrease (Diez-Gonzalez et al., 1998; Tkalcic et al., 
2000), no change (Zhang et al., 2010), or increase (Van Baale et al., 2004) in shedding of STEC 
O157 in cattle feces when compared to grain based diets.  Similarly, studies have indicated a 
higher fecal prevalence of STEC O157 when cattle are fed greater than 25% distiller’s grains 
compared to diets with less than 25% distiller’s grains (Jacob et al., 2008; Wells et al., 2009; 
Jacob et al., 2010).  In addition, the type of grain and processing methods may significantly 
impact the STEC population within cattle’s gastrointestinal tract (Fox et al., 2007).  Research has 
indicated an increased fecal shedding of STEC O157 in cattle fed a barley-based diet compared 
to a corn-based diet (Dargatz et al., 1997; Buchko et al., 2000; Berg et al., 2004).  Further, 
studies on the differences in processing method of grains (i.e. corn and barley) have shown a 
greater STEC O157 burden in cattle receiving a steam-rolled or steam-flaked grain compared to 
dry-rolled grain diet (Fox et al., 2007; Depenbusch et al., 2008; Callaway et al., 2009).  Although 
researchers have proposed multiple hypotheses for increased STEC shedding due to specific diet 
ingredients, additional data are required to determine the exact physiological factors that affect 
shedding.  Further, it seems unlikely that commercial feedlot operations are going to alter cattle 
diets based on fecal shedding of STEC due to the potential financial implications (i.e. potential 
loss in cattle performance and carcass characteristics) of adopting unique diets combinations. 
Administration of prebiotics is currently being tested for the ability to alter STEC 
shedding in cattle.  Prebiotics are non-digestible organic compounds, such as oligosaccharides, 
trisaccharide and dietary fiber, which cannot be directly utilized by animals, but have the ability 
to be digested by specific populations of the microflora (Houdijk et al., 1998; Willard et al., 
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2000).  Some researchers have hypothesized that beneficial bacteria are able to outperform the 
pathogens by utilizing prebiotics (Schrezenmeir et al., 2001), while others believe that prebiotics 
have the potential to target specific segments of the microbial population by competitive 
exclusion (Zopf and Roth, 1996; Baines et al., 2011).   To date, it is unlikely that commercial 
feedlot operations are willing to implement prebiotics as a pre-harvest intervention due to their 
expense, limited data, and the ability of ruminal microorganism to degrade a range of prebiotic 
compounds.   
Direct-fed microbials are another pre-harvest intervention that is being explored for their 
ability to control STEC shedding. Traditionally, direct-fed microbials have been fed in cattle 
diets to enhance performance (Elam et al., 2003; Callaway et al., 2014).  Direct-fed microbials 
utilize commensal microbial cultures to beneficially affect the microflora of the gastrointestinal 
tract through either the potential upregulation of desirable microbial populations or by physically 
attaching to the gastrointestinal epithelium to prevent harmful pathogens (e.g. STEC) from 
thriving (Zhao et al., 1998; Kim et all., 2008; Wisener et al., 2014).  By far the most studied 
direct-fed microbial products include a Lactobacillus-based strain (Wisener et al., 2014).  Studies 
have reported significant reductions of STEC O157 shedding in cattle fed a DFM comprising of 
L. acidophilus (Brashears et al., 2003; Elam et al., 2003; Vasconcelos et al., 2008; Hanford et al., 
2011).   Further studies have indicated efficacy of a modified direct-fed microbial culture, which 
includes the L. acidophilus and Propionibacterium freudenreichii strains, with an overall STEC 
O157 fecal shedding reduction between 20% to 75% (Younts-Dahl et al., 2004; Stephens et al., 
2007; Arthur et al., 2010; Cernicchiaro et al., 2010).  However, the published literature has 
indicated multiple dosing volumes (e.g., high versus low) for some of the DFM products due to 
the potential differential efficacy and performance affects at either a high or low dose (Wisener 
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et al., 2014).  However, a recent study indicated no evidence for a difference in EHEC based on a 
high versus low dose of a DFM product (i.e., Bovamine®) (Luedtke et al., 2016).  To date, the 
use of DFM has become a relatively common practice in commercial feedlot operations due to 
their potential ability to improve cattle performance and reduce pathogens (NAHMS, 2013; 
Callaway et al., 2014).  However, additional large commercial feedlot trials are required to 
quantify both the pre-harvest food-safety (i.e. STEC-7 shedding) and performance impacts 
associated with the implementation of direct-fed microbial feeding, as the current literature 
includes studies with key differences in study design, statistical power, and pen size (Wisener et 
al., 2014). 
Along with other pre-harvest interventions, vaccines have been tested for their ability to 
reduce STEC O157 shedding.  Although most vaccines are utilized to stimulate the immune 
system of animals to protect against disease, the Siderophore Receptor and Porin protein (SRP) 
and the Type III secretory proteins (Type III) vaccines are uniquely produced to target different 
physiological aspect of STEC O157 due to the natural exposure and commensal, asymptomatic 
nature of the organism in cattle (Callaway et al., 2014; Smith, 2014).  More specifically, the SRP 
based vaccine disrupts iron uptake by the bacteria, effectively starving STEC of iron which leads 
to cell lysis (Emery et al., 2000; Thornton et al., 2009), while the antibody production against the 
Type III prevents villi adherence and colonization of STEC in the gastrointestinal tract of cattle 
(Dziva et al., 2007; Moxley et al., 2009).  Recently, there were two systematic reviews indicating 
the efficacy of the SRP and Type III vaccines against STEC O157 shedding in cattle feces 
(Snedeker et al., 2012; Varela et al., 2012) with research indicating greater than 25% reduction 
of STEC O157 shedding in cattle administered the SRP vaccine (Thornton et al., 2009; Thomson 
et al., 2009; Wileman et al., 2010) or the Type III vaccine (Potter et al., 2004; Peterson et al., 
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2007; Smith et al., 2009).  Further, these studies reported no adverse cattle performance effects 
for vaccinated versus non-vaccinated animals.  However, in the reported studies, cattle in the 
control groups were re-handled and administered a placebo, and research on other cattle vaccines 
have indicated negative cattle performance effects due to immunization or handling effects of 
cattle (Voisinet et al., 1997; Rodrigues et al., 2015).  Currently, the three dose regimen of the 
SRP vaccine is the only commercially available vaccine approved in the United States for 
reducing STEC O157 shedding in cattle feces, and the three dose regimen of the Type III vaccine 
is no longer being produce.  However, the published literature has not reported a wide-spread 
implementation of the SRP vaccine in commercial feedlot operations.  Limited use of the SRP 
vaccine in commercial feedlot operations may be due to the lack of economic incentives, lack of 
data on the economic feasibility of these products, ease of product incorporation into existing 
protocols, or the potential performance impacts for the implementation of pre-harvest 
interventions (Snedeker et al., 2011; Callaway et al., 2014; Smith, 2014).   
 
 
 Conclusion 
 This review of the scientific literature regarding the epidemiology of STEC-7 in 
commercial feedlot operations exposes critical knowledge gaps in pre-harvest intervention 
efficacy and performance impacts, as well as a general lack of prevalence data for non-O157 
STEC at different hierarchical levels in feedlot production systems.  In order to identify and 
validate pre-harvest interventions that may significantly reduce the fecal load prior to harvest and 
subsequent risk of food contamination, additional research is required to determine the important 
risk factors of STEC-7 shedding in cattle feces.  Understanding the transfer of STEC-7 along the 
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fecal to hide to carcass pathways likely depends on both prevalence and concentration along the 
beef production systems.  Previous research indicates that pre-harvest interventions for STEC 
O157 may have the ability to compliment post-harvest interventions and decrease the risk of 
STEC transfer to beef at harvest; however, there are limited data illustrating the impact of pre-
harvest interventions on STEC-7 prevalence at each step along the beef production system.  
Although there is a growing body of literature for pre-harvest interventions, additional data are 
required to determine the efficacy of these products in commercial feedlot operations from 
different geographic locations with different management practices.  In addition, there is a need 
to determine the effects of using multiple pre-harvest interventions at different time points along 
the beef production system.  Data regarding the concentration, prevalence, and transmission of 
STEC-7 within cohorts of cattle are necessary to improve the knowledge on the epidemiology of 
STEC-7.  Further, there is a need for a more comprehensive understanding of the economic 
impacts of implementing pre-harvest interventions in commercial feedlot operations.   
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 Abstract 
Our primary objective was to determine the efficacy of a siderophore receptor and porin 
proteins-based vaccine (VAC) and a Lactobacillus acidophilus-based direct-fed microbial 
(DFM) against fecal shedding of E. coli O157:H7 in commercial feedlot cattle fed a corn grain-
based diet with 25% distiller’s grains. Cattle projected to be on a finishing diet during the 
summer were randomly allocated into 40 study pens within ten blocks based on allocation dates.  
Blocks were complete; each of the four pens within a block was randomly assigned one 
treatment: control, VAC, DFM, or VAC+DFM.  The DFM was fed (106 CFU/animal/day of 
Lactobacillus) throughout the study periods (84 - 88 days) and cattle were vaccinated at 
enrollment and again three weeks later. Fresh fecal samples (30/pen) from pen floors were 
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collected weekly for four consecutive weeks (study days 52 to 77). Two concurrent culture 
procedures were used to enable estimates of E. coli O157:H7 shedding prevalence and 
prevalence of high shedders. From 4,800 total samples, 1,522 (31.7%) were positive for E. coli 
O157:H7 and 169 (3.5%) were considered high shedders. Pen-level linear mixed models were 
used for data analyses. There were no significant interactions among treatments and time of 
sampling. However, vaccinated pens had lower (P < 0.01) overall prevalence of E. coli O157:H7 
(model-adjusted mean ± SEM = 17.4 ± 3.95%) and lower (P < 0.01) prevalence of high shedders 
(0.95 ±0.26%) than unvaccinated pens (37.0±6.32% and 4.19±0.81%, respectively). There was 
no evidence of a DFM effect on either measure of E. coli O157:H7 shedding. Results indicate 
that a two-dose regimen of the vaccine significantly reduces fecal prevalence of E. coli O157:H7 
(vaccine efficacy of 53.0%) and prevalence of E. coli O157:H7 high shedders (vaccine efficacy 
of 77.3%) in commercial feedlot cattle reared in the summer on a finishing diet with 25% 
distiller’s grains. 
 
 Abbreviations 
ADG – average (mean) daily weight gain 
DFM – direct fed microbial 
DG – distiller’s grains   
F:G – ratio of feed weight to gained weight of cattle 
IMS – immunomagnetic separation  
SRP – siderophore receptor and porin proteins-based vaccine 
VAC – vaccinated group 
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 Introduction 
Escherichia coli O157:H7 is an important cause of food-borne illness [1]. In addition to 
public health concerns, the economic impact of E. coli O157:H7 has been severe [2]. Pre-harvest 
interventions that reduce fecal shedding of these bacteria in cattle have the potential to enhance 
food safety and reduce economic impacts of E. coli O157:H7. It has been proposed that beef 
processors extend their food safety plans to the pre-harvest phase by purchasing cattle from 
producers who implement E. coli O157:H7 control programs [3]. However, most pre-harvest 
interventions have not been validated for the diverse production settings in the beef industry [3-
5].   Both prevalence and concentration of E. coli O157:H7 in cattle feces are associated with 
beef contamination; occasionally cattle shed E. coli O157:H7 at high concentrations (e.g., > 104 
CFU/g of feces; hereafter “high shedders”) [6-8].  Although few factors associated with shedding 
have been consistently observed, cattle shed more E. coli O157:H7 in summer than winter 
months [4,9,10].  Dietary components also influence fecal shedding [4,9]. For instance, diets 
containing distillers grains (DG), a co-product of the ethanol industry, can increase E. coli 
O157:H7 fecal shedding [9,11,12].  Since efficacy of pre-harvest interventions is most important 
during periods of high fecal shedding [13], data from studies of cattle fed DG-supplemented 
diets in the summer months are important. 
Two interventions that are commercially available in the United States and have 
demonstrated efficacy for reducing E. coli O157:H7 shedding in cattle are a siderophore receptor 
and porin (SRP) proteins-based vaccine and a Lactobacillus acidophilus-based direct-fed 
microbial (DFM) [5,14].  This DFM  includes a strain of Lactobacillus acidophilus (NP51) 
shown to have inhibitory effects on E. coli O157:H7 [10].  The vaccine uses SRP proteins as 
antigens so immunized animals produce anti-SRP antibodies that bind to outer membrane 
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proteins of bacterial cells and block iron transport [15].  Although literature indicates potential 
benefits of these products, there is a need for additional data on efficacy in commercial settings 
[5,14]. Further, there are no data on concurrent use of these interventions. Therefore, our primary 
objective was to determine the efficacy of intervention programs including the SRP vaccine, the 
DFM, or both products against fecal shedding of E. coli O157:H7 in pens of commercial feedlot 
cattle fed a DG-supplemented finishing diet during the summer.  A secondary objective was to 
evaluate impacts of intervention programs on cattle health and performance outcomes as 
compared to control cattle reared using standard practices. 
 
 Materials and methods 
 A commercial feedlot in Nebraska, USA was identified based on criteria that included: 
capacity to fill 40 pens with cattle on a finishing diet during summer, use of a finishing diet that 
included > 25% DG, ability to feed the DFM, willingness to vaccinate cattle according to 
protocol, and ability to perform research.  Individual cattle were eligible for inclusion if 
projected to be on a finishing diet during summer; with this feedlot’s management system, cattle 
had to be enrolled approximately 100 days prior to harvest of the first subset. Following a brief 
transition period, cattle were fed a finishing diet which included (dry matter basis): 46.4% high 
moisture corn, 25.0% wet DG, 17.0% corn gluten, 7.1% silage, 2.5% steep, and 2.0% 
micro/minerals mix (including 280 mg of monensin/animal/day and 90 mg of tylosin/animal/day 
(Elanco Animal Health, Greenfield, IN, USA)).  The feedlot’s standard operating procedures 
were followed for cattle care and management; sprinklers were used as needed to reduce heat 
stress risks. Kansas State University (KSU) Institutional Animal Care and Use Committee 
approved the study (#2723).   
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The study was designed as a randomized complete block with a 2 x 2 factorial treatment 
structure. A priori sample size estimates were generated by data simulation and power 
calculations; assumptions included: 40% mean control group prevalence of E. coli O157:H7 
[16], 25% mean prevalence in pens receiving an intervention, and no interaction among 
interventions. Forty pens (10/treatment) and 120 samples (30/week for four weeks) per pen were 
considered sufficient for 80% statistical power to detect expected treatment differences with a 
5% Type 1 error.  Individual cattle were randomly allocated to 40 pens grouped in 10 blocks 
(defined based on allocation dates; March 31 through May 14, 2011). Within block, one pen each 
was randomly allocated to one treatment: control, administered vaccine (VAC), fed DFM 
(DFM), or both VAC and DFM (VAC + DFM).  Cattle in VAC and VAC+DFM groups were 
administered a 2 mL dose of the vaccine subcutaneously (SC, 1 ½ inch needle) in the left lower 
neck on study day 0 and again three weeks later (E. coli SRP® vaccine, Pfizer Animal Health, 
New York, NY, USA;  lot # 840-0006, expiration August 19, 2011). Cattle allocated to DFM or 
control groups never received a placebo and were not re-handled three weeks following 
enrollment.  The DFM, labeled for 106 CFU/animal/day of Lactobacillus acidophilus and 109 
CFU/animal/day of Propionibacterium freudenreichii, was fed throughout the study periods 
(Bovamine®, Nutrition Physiology Corp., Guymon, OK, USA).  On study day 0, all cattle 
received a herpes virus vaccine (Pyramid IBR, Boehringer Ingelheim Vetmedica Inc., St. Joseph, 
MO, USA; 2 mL, SC) and a growth promoting implant (Synovex Choice, Pfizer Animal Health, 
New York, NY, USA; SC in the left ear).  
 The feedlot’s computer system randomly allocated animals to treatment groups as they 
were handled on study day 0.  For each block, four contiguous pens within the feedlot were 
identified and pen locations for treatment groups within blocks were then randomly allocated 
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using the computer’s randomization algorithm. The primary study outcome was within-pen E. 
coli O157:H7 prevalence, whereas within-pen prevalence of high shedding animals was 
considered a secondary outcome. Thus, each sample was classified twice (independently) as 
positive or negative to: 1) a culture procedure including immunomagnetic bead separation (IMS) 
to assess fecal shedding, and 2) a direct plating culture procedure to assess high shedding.  
Laboratory personnel were blinded to treatment: samples were tracked only by sequential 
numbers.  Cumulative (study period) risks of cattle mortality and culling, and cattle performance 
measures also were considered secondary outcomes and were collected by feedlot staff blinded 
to treatment group; personnel administering treatments did not collect health or performance 
data. Average (mean) daily weight gain (ADG) and feed conversions (F:G; ratio of feed weight 
to gained weight of cattle) were calculated as: 
ADG = Total Weight Gain of Cattle (out-weight for cattle finishing the trial + out-weight of 
cattle culled + out-weight of dead cattle – total enrollment weight) ÷ Total Cattle Days  
F:G = Total Dry Matter Weight of Feed ÷ Total Weight Gain (as defined above)  
 Feedlot personnel performed daily health monitoring following standardized procedures. 
Animals were weighed individually at the beginning and end of the study. Fresh fecal samples 
(30/pen) from animals observed defecating were collected from separate pats in multiple areas 
throughout the pen.  Care was taken to avoid ground contamination.  Pens were sampled weekly 
for four consecutive weeks prior to study end-dates for each block.  Samples (approximately 30 
g) were placed in sterile bags, stored in coolers, and transported to KSU for refrigeration (4°C) 
until the following morning. Samples were cultured for E. coli O157:H7 using IMS and direct 
plating methods previously described [7,8].  Confirmation included a multiplex PCR for 
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identifying the rfbE (O157), eae (intimin), stx1 (Shiga toxin 1), stx2 (Shiga toxin 2), hlyA 
(hemolysin), and fliC (H7) genes [17].   
Pen-level general and generalized linear mixed models (LMM and GLMM, respectively) 
were used to assess potential treatment effects.  For response variables recorded as pen-level 
proportions, data were fit using a GLMM with a binomial distribution and a logit link. 
Prevalence outcomes were the proportion of samples positive of the total samples collected 
within the pen at each sampling.  Mortality and culling risks were proportions based on the 
number of animals that died or were culled, respectively, during the study period out of the total 
number of animals enrolled within the pen. Data on ADG and F:G were modeled using LMM 
that assume a Gaussian distribution. For all models, random effects were fitted to recognize 
block as the clustering factor and pen as the experimental unit for treatment.  For E. coli data, 
additional random effects were used to account for pen-specific repeated measures over time.  
Independent variables included treatments (VAC, DFM, VAC x DFM interaction), and for E. 
coli data, effects of time and time-by-treatment interaction.  Model diagnostics were based on 
studentized residuals (LMM) and functions of the Pearson2 statistic (GLMM).  P values < 0.05 
were considered significant.  Model-adjusted means (lsmeans back transformed to original scale) 
and SE were reported, and used to estimate vaccine efficacy using standard formula [18].     
 
 Results 
Study pens were filled with 17,148 steers. Pen sizes ranged between 398 and 464 steers 
(mean = 430.0). Mean weight at enrollment was 378.4 kg with no significant difference among 
treatment groups. Projected finishing days were re-assessed by feedlot personnel during the 
study and determined to be 14 days earlier than expected. Resulting end-dates for study blocks 
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ranged between June 20 and August 3, 2011; thus, days on study ranged between 84 and 88 
(mean = 86.6 days) across blocks. Sampling began approximately five weeks prior to projected 
study-end for each block, resulting in samples collected (for four consecutive weeks) between 
study days 52 to 56 (week one), 59 to 63 (week two), 66 to 70 (week three), and 73 to 77 (week 
four).  
From 4,800 total samples, 1,522 (31.7%) were positive for E. coli O157:H7 and 169 
(3.5%) were considered high shedders; percentages by week of sampling are provided in Figure 
1. Isolates considered E. coli O157:H7 were positive for the rfbE (100%), eae (99.8%), stx1 
(66.2%), stx2 (99.5%), hlyA (99.7%), and fliC (99.8%) genes. Escherichia coli O157:H7 were 
isolated at least once from all pens (100%) and 34 pens (85%) had at least one high shedder.  
Within pens, unadjusted cumulative prevalence of shedding (across sampling times) ranged 
between 1.7% and 66.7% and high shedder prevalence ranged between 0% and 12.5%.  
Analysis of within-pen prevalence of E. coli O157:H7 shedding data indicated no 
significant two- or three-way interactions among treatments and time of sampling. There also 
was no significant main effect of DFM (Table 1). However, a main effect of VAC was apparent, 
such that VAC decreased prevalence of fecal shedding (Table 2). Figure 2 illustrates estimated 
efficacy (53.0%) of vaccination for reducing fecal prevalence of E. coli O157:H7 and means for 
the contrast between vaccinated and non-vaccinated pens (P < 0.01). A main effect of sampling 
time on fecal shedding was also apparent (P = 0.02), whereby mean prevalence on sampling 
week two differed from prevalence on week four; no other week-to-week differences were 
detected. Means (SEM) were 24.6% (5.07), 20.7% (4.53), 27.2% (5.39) and 32.4% (5.92) for 
sampling weeks one through four, respectively. 
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Regarding high shedder prevalence, results indicated no significant two- or three-way 
interactions among treatments and time of sampling, and no significant main effects of DFM 
(Table 1) or sampling week. However, a significant effect of VAC was identified, whereby 
vaccination decreased the prevalence of high shedders (Table 2).  Figure 2 illustrates the 
difference in means for vaccinated and non-vaccinated pens (P < 0.01) and the estimated vaccine 
efficacy (77.3%) for reducing prevalence of E. coli O157:H7 high shedders. 
Effects of treatment were apparent on both ADG and F:G, but there were no significant 
interactions between VAC and DFM.  For ADG, there was no significant DFM effect (Table 1), 
but the VAC effect was significant (Table 2).  For F:G, effects of DFM (Table 1) and VAC 
(Table 2) were both statistically significant.  There was no evidence of VAC and DFM 
interactions, main effect of DFM (Table 1), or main effect of VAC (Table 2) on either mortality 
or culling risks.   
 
 Discussion 
An important finding of this study is that two doses of the SRP® vaccine applied in a 
commercial feedlot reduced E. coli O157:H7 shedding by more than 50% and reduced high 
shedders by more than 75%. These results from a cattle population with relatively high levels of 
E. coli O157:H7 have important practical implications since efficacy of pre-harvest interventions 
is most important when prevalence is high [13].  Another important finding is that the 
commercial DFM (Bovamine®) had no effect on E. coli O157:H7 fecal shedding. These results 
also have practical significance since end-users of pre-harvest interventions may wonder whether 
these commercially available products – the SRP® vaccine and the Bovamine® DFM – are 
equally efficacious. Results also indicate that DFM-fed cattle may have improved performance 
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whereas cattle in vaccinated pens had relatively poorer performance. Performance effects need to 
be further quantified since cattle performance affects beef production costs, and the adoption of 
pre-harvest control programs will be affected by all costs associated with implementation.    
Study cattle were fed a diet with 25% DG during the summer; thus, the interventions 
were tested in a situation when fecal shedding of E. coli O157:H7 was expected to be high. 
Feeding DG to cattle can increase fecal shedding of E. coli O157:H7 approximately two- to 
three-fold [9,11,12]. Seasonal effects associated with E. coli O157:H7 shedding (higher in the 
summer) also has been well documented; study data (Figure 1) demonstrate a well-described 
seasonal pattern [4,16,19].  The sample-level prevalence for high shedders (3.5%) and overall 
fecal shedding (31.7%) were relatively high, but numerically similar to estimates from 
comparable populations. Reports on summer-harvested cattle included prevalence estimates for 
high shedders of 3.7% [7] and 3.3% [8].  Recent estimates of overall fecal prevalence in 
summer-fed feedlot cattle have ranged between 37% and 10%, but within-pen prevalence is 
highly variable [16,20,21].  Thus, the range in cumulative within-pen prevalence (1.7% to 
66.7%) reported in this current study is consistent with previous reports.  While diagnostic 
sensitivity and specificity of culture methods used in this study are not perfect for identifying 
fecal shedding and high shedding [22], any misclassification would be expected to be non-
differential with respect to treatments.  Further, these methods have previously provided useful 
data on fecal shedding relative to important food safety parameters such as E. coli O157:H7 
carcass and hide prevalence [7,8]. Gene profiles of isolates recovered in this study are similar to 
those previously reported; indicating that the E. coli O157:H7 isolates have potential for human 
virulence [23,24]. 
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This is the first published study demonstrating efficacy of a 2-dose regimen of the 
commercially available SRP® vaccine for reducing both the prevalence of E. coli O157:H7 
shedding and high shedding in a large-pen commercial feedlot. Although vaccine efficacy has 
been demonstrated previously [15,25,26], key features differ between previous studies and the 
study reported here. The SRP® vaccine was first shown to reduce fecal shedding in young calves 
orally inoculated with E. coli O157:H7 [28].  Cattle that were naturally shedding E. coli 
O157:H7 in a research feedlot were used to show that 3 mL doses of vaccine reduced fecal 
shedding; a dose-response trend was also observed [25].  In one feedlot study, a 2-dose regimen 
of the vaccine reduced fecal prevalence, and in another study, a 3-dose regimen reduced fecal 
concentration [26].  A cow-calf study found no significant vaccine effects, but cattle were 
vaccinated at much different production phases [27].  In addition to differing study designs, 
vaccine dosages, or study populations, this commercial feedlot study reported here utilized very 
large pens while others used smaller pens (< 70 animals/pen) [15,25,26].  A recent systematic 
review indicating efficacy of the SRP® vaccine suggested that further studies in commercial 
settings were needed [14].   
 No evidence for any DFM (Bovamine®) effect on E. coli O157:H7 fecal shedding was 
observed, contradicting some results of empirical studies and a systematic review indicating 
efficacy of this Lactobacillus acidophilus strain (NP51) [5,10,28-32].  Possibly larger pen sizes 
and a lower dose of product in the current study compared to previous studies could explain 
seemingly contradictory results. This commercial feedlot study utilized large pens while many 
other studies used much smaller (< 10 animals/pen) pens [28-32].  Further, efficacy of this DFM 
for reducing E. coli O157:H7 may be improved at a higher dose [10,29,32]. The commercial 
low-dose Bovamine® product (106 CFU/head/d of Lactobacillus) was utilized in the current study 
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because of the perception that this product can reduce fecal shedding and also improve cattle 
performance.  Indeed, there are important practical implications if a pre-harvest control program 
could reduce E. coli O157:H7 fecal shedding while improving animal performance. 
A meta-analysis demonstrated that this DFM can improve feedlot cattle performance 
[33]; reported summary effects were similar to effects reported here. However, results indicating 
lower weight gain per day and less efficient feed conversion for vaccinated versus unvaccinated 
pens are novel. Previous feedlot studies with this vaccine did not detect significant differences in 
cattle performance [15].  However, in previous studies both vaccine and control groups were 
handled on re-vaccination days and controls were given a placebo. Further, previous studies had 
much smaller sample sizes to detect differences with half as many pens (20) and much fewer 
animals overall (< 1,300) than the current study (40 and > 17,000, respectively). For the current 
study, controls were not re-handled or given a placebo during vaccinations times because the 
feedlot would not normally do these procedures; the intent of assessing performance was to 
evaluate the total program (not just the vaccine) as compared to normal production practices. 
Since production costs must be considered for implementation of a vaccination program, further 
research specifically designed for evaluating performance effects may be warranted. 
 
 Conclusions 
We found the overall fecal prevalence of E. coli O157:H7 and prevalence of high 
shedders in this large commercial feedlot population were relatively high as expected for 
summer-fed cattle supplemented with distiller’s grains.  We conclude that this DFM, Bovamine® 
(labeled for 106 CFU/head/d of Lactobacillus), administered alone or in combination with the 
SRP® vaccine, does not significantly affect fecal shedding.  However, the SRP® vaccine 
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significantly reduces fecal prevalence of E. coli O157:H7 and prevalence of high shedders, and 
therefore may be an effective intervention for E. coli O157:H7 control in commercial feedlots. 
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Table 2.1 Model-adjusted1 means, standard errors (SEM), 95% confidence intervals (CI), and P values for comparisons of 
outcome measures between pens of feedlot cattle that were fed a direct-fed microbial2 (DFM) containing Lactobacillus 
acidophilus and Propionibacterium freudenreichii (n = 20) and pens that were not fed the DFM (n = 20). 
 
 
 
 
 
 
 
 
1From linear mixed models accounting for allocation of pens within blocks (and repeated measures on pens over time for fecal 
and high shedder prevalence) 
2Bovamine® (labeled for 106 CFU/animal/day of Lactobacillus acidophilus and 109 CFU/animal/day of Propionibacterium 
freudenreichii), Nutrition Physiology Corp., Guymon, OK, USA) 
 
 
  
 Fed DFM  No DFM   
Outcome measures Mean SEM CI  Mean SEM CI  P value 
Fecal prevalence, %  25.8  5.24 16.6 – 37.9  26.2  5.26 16.9 – 38.3  0.94 
High shedder prevalence, %  2.16  0.49 1.36 – 3.42  1.87  0.47 1.12 – 3.11  0.59 
Average daily weight gain, kg  1.48  0.02 1.43 – 1.53  1.46  0.02 1.40 – 1.51  0.09 
Feed to gain ratio 6.01  0.08 5.84 – 6.17  6.14  0.08 5.99 – 6.31  0.03 
Mortality risk, %  1.14  0.11 0.93 – 1.40  1.08  0.11 0.87 – 1.34  0.70 
Culling risk, %  0.42  0.15 0.21 – 0.86  0.41  0.14 0.21 – 0.86  0.78 
53 
 
Table 2.2 Model-adjusted1 means, standard errors (SEM), 95% confidence intervals (CI), and P values for comparisons of 
outcome measures between pens of feedlot cattle that were vaccinated twice with a siderophore receptor and porin proteins-
based vaccine2 (n = 20) and pens that were not vaccinated (n = 20). 
 
 
 
 
 
 
 
1From linear mixed models accounting for allocation of pens within blocks (and repeated measures on pens over time for fecal 
and high shedder prevalence) 
2E. coli SRP® vaccine, Pfizer Animal Health, New York, NY, USA 
 
  
    Vaccinated  Non-Vaccinated   
Outcome measures Mean SEM CI  Mean SEM CI  P value 
Fecal prevalence, %  17.4  3.95 10.7 – 27.0  37.0  6.32 25.2 – 50.6  < 0.01 
High shedder prevalence, %  0.95  0.26 0.54 – 1.67   4.19  0.81 2.82 – 6.20  < 0.01 
Average daily weight gain, kg  1.45  0.02 1.39 – 1.50  1.49  0.02 1.44 – 1.54  0.01 
Feed to gain ratio 6.14  0.08 5.99 – 6.31   6.01  0.08 5.85 – 6.18  0.04 
Mortality risk, %  1.14  0.11 0.93 – 1.40  1.08  0.11 0.87 – 1.34  0.70 
Culling risk, %  0.41  0.14 0.20 – 0.83  0.43  0.15 0.21 – 0.87  0.78 
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Figure 2.1 Descriptive data on fecal samples from feedlot cattle that tested positive for E. 1 
coli O157:H7 shedding and E. coli O157:H7 high shedding for each week during the 2 
sampling period.  Data are summarized across all pens (treatments and blocks) sampled for 3 
each week.  4 
 5 
 6 
 7 
 8 
  9 
12.5
18.1
13.5
18.0
48.3
40.7 39.3 40.3
35.2
28.8
51.7
0.4 0.8
1.9 2.8
5.4
7.5
4.7 3.3
1.9 2.5
4.2
0
10
20
30
40
50
60
2
1
-M
ay
-2
0
1
1
n
=
2
4
0
2
8
-M
ay
-2
0
1
1
n
=
3
6
0
4
-J
u
n
-2
0
1
1
n
=
4
8
0
1
1
-J
u
n
-2
0
1
1
n
=
6
0
0
1
8
-J
u
n
-2
0
1
1
n
=
4
8
0
2
5
-J
u
n
-2
0
1
1
n
=
6
0
0
2
-J
u
l-
2
0
1
1
n
=
6
0
0
9
-J
u
l-
2
0
1
1
n
=
6
0
0
1
6
-J
u
l-
2
0
1
1
n
=
4
8
0
2
3
-J
u
l-
2
0
1
1
n
=
2
4
0
3
0
-J
u
l-
2
0
1
1
n
=
1
2
0
P
er
ce
n
t 
o
f 
sa
m
p
le
s 
te
st
in
g
 p
o
si
ti
v
e 
(%
)
Date  of collection and number of fecal samples
 O157:H7 positive
High shedder positive
 55 
 
Figure 2.2 Vaccine efficacy estimates and corresponding model-adjusted1 means (with 10 
standard error bars) demonstrating the effects a siderophore receptor and porin proteins-11 
based vaccine for controlling overall fecal prevalence of E. coli O157:H7 and prevalence of 12 
E. coli O157:H7 high shedders in pens of commercial feedlot cattle.  A significant vaccine 13 
effect was demonstrated for both measures of E. coli O157:H7 prevalence (P values < 14 
0.01)1.  15 
 16 
1From generalized linear mixed models accounting for allocation of pens within blocks and 17 
repeated measures on pens over time. 18 
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Chapter 3 - Performance and carcass characteristics of commercial 20 
feedlot cattle from a study of vaccine and direct-fed microbial effects 21 
on E. coli O157:H7 fecal shedding 22 
 23 
 24 
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 26 
*Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, 27 
Kansas, 66506; §Department of Statistics, Kansas State University, Manhattan, Kansas, 66506                 28 
‡Department of Agricultural Sciences, West Texas A&M University, Canyon, Texas, 79016; 29 
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 33 
 Abstract 34 
 35 
The objective of this study was to quantify cattle performance and carcass characteristics 36 
associated with administration of a siderophore receptor and porin proteins-based vaccine (VAC) 37 
and a direct-fed microbial (DFM) which were originally evaluated for their impact on E. coli 38 
O157:H7 fecal shedding in a commercial feedlot population. Cattle (n=17,148) were randomly 39 
allocated into 40 pens grouped by allocation dates into 10 complete blocks; pens within block 40 
were randomly allocated to control, VAC, DFM, or VAC+DFM treatment groups in a 2x2 41 
factorial design. The DFM (Bovamine) was fed at the labeled dose of 106 CFU/animal/day of 42 
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Lactobacillus acidophilus for the duration of the intervention period (mean=86.6 d). The VAC 43 
cattle were vaccinated on days 0 and 21 whereas unvaccinated cattle were not given a placebo or 44 
re-handled on day 21. Data were analyzed using general and generalized linear mixed models 45 
that accounted for the study design. Main effects of DFM and VAC are reported as there were no 46 
significant treatment interactions for any of the outcomes evaluated. Vaccinated cattle had lower 47 
total weight gain (P < 0.01), ADG (P = 0.03), and cumulative DMI during the intervention 48 
period (P < 0.01) as compared to unvaccinated cattle, while the DFM increased total weight gain 49 
(P = 0.03) and G:F (P = 0.05) during the intervention period. Daily DMI was decreased (P < 50 
0.01) in vaccinated pens as compared to unvaccinated pens during a five day period immediately 51 
following revaccination. After the intervention period was completed, cattle were sorted 52 
following the standard operating procedure for the feedlot and all cattle were fed the DFM from 53 
that point until harvest. Each steer was individually identified through harvest. At harvest, 54 
vaccinated cattle had more total days on feed (P < 0.01) with a larger HCW (P = 0.01) than non-55 
vaccinated cattle, whereas cattle not fed the DFM during the intervention period had a 56 
significantly larger HCW (P < 0.01) than those fed the DFM during the intervention period. We 57 
conclude that the use of these direct-fed microbial and vaccine products have differential and 58 
independent effects on cattle performance and carcass characteristics in a commercial feedlot 59 
setting. Although the magnitude of these effects may vary among production systems, a more 60 
comprehensive understanding of the potential production costs of pre-harvest food safety 61 
pathogen control programs is essential if such programs are to be fully adopted in the industry.  62 
 63 
 58 
 
 Introduction 64 
 For the past two decades, Escherichia coli O157:H7 has been recognized as a major 65 
foodborne pathogen that is economically important to the beef industry (NCBA, 2003). As 66 
emphasis increases for implementation of pre-harvest food safety interventions, the lack of data 67 
on potential live and carcass performance effects associated with the pre-harvest interventions 68 
has become more apparent. These effects need to be further quantified since cattle performance 69 
directly affects beef production costs and subsequent business decisions. Thus, the adoption of 70 
pre-harvest control programs will likely be affected by all costs and benefits associated with 71 
implementation. 72 
Previously, we evaluated the efficacy of two pre-harvest interventions, a siderophore 73 
receptor and porin (SRP) proteins-based vaccine (VAC) and a Lactobacillus acidophilus-based 74 
direct-fed microbial (DFM; Bovamine), on E. coli O157:H7 fecal shedding in feedlot cattle (Cull 75 
et al., 2012). A preliminary assessment of cattle weight gain and feed conversion during the 76 
study period indicated potential differences in performance among treatment groups (Cull et al., 77 
2012). Previous literature on the vaccine demonstrated no significant effects on feedlot cattle 78 
performance; however, control cattle in these studies were handled and given a placebo which 79 
would not be a typical production practice (Thomson et al., 2009). Previous literature on the 80 
DFM demonstrates positive or neutral effects on performance outcomes; generally, a lower dose 81 
of the DFM was thought to increase performance as compared to animals fed a higher dose or no 82 
DFM (Loneragan and Brashears, 2005). Although literature indicates potential food safety or 83 
performance benefits of these products, there is a need for more comprehensive performance 84 
data in a commercial feedlot setting (Cull, 2012). Therefore, our objective was to further 85 
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quantify the live and carcass performance of cattle administered VAC, DFM, or both in a large-86 
scale commercial feedlot system. 87 
 88 
 Materials and Methods 89 
 Study Population 90 
Previously, Cull et al. (2012) described a commercial feedlot study in the central USA 91 
that took place during the summer months and included 17,148 head of steers randomly allocated 92 
to 40 pens grouped into 10 blocks.  Within each block, a pen was randomly allocated to one 93 
treatment group: control (CON), vaccine (VAC), direct-fed microbial (DFM) or both VAC and 94 
DFM (VAC + DFM). Cattle in the VAC and VAC + DFM groups were vaccinated at allocation 95 
on day 0 and re-vaccinated 21 days later with a SRP vaccine (E. coli SRP vaccine, Zoetis Animal 96 
Health, New York, NY, USA); re-vaccination occurred pen-side with the entire pen of cattle 97 
processed within seventy minutes or less.  Cattle allocated to CON or DFM groups never 98 
received a placebo vaccine and were not re-handled at the re-vaccination time.  Cattle allocated 99 
to the DFM or VAC + DFM were fed a product with Lactobacillus acidophilus (NP51) and 100 
Propionibacterium freudenreichii at a dose of 106 CFU/head/day and109 CFU/animal/day, 101 
respectively, throughout the study period (Bovamine, Nutrition Physiology Corp., Guymon, OK, 102 
USA).  All animals were weighed upon allocation to the study with the mean weight at 103 
enrollment of 377.6 kg (range 350.2 – 403.9 kg); study animals had previously been on feed for 104 
60-90 days before allocation.  After a brief step-up period (< one week), cattle were fed twice 105 
daily a finishing diet which included (dry matter basis): 46.4% high moisture corn, 25.0% wet 106 
distillers grain,  17.0% corn gluten, 7.1% silage, 2.5% steep, and 2.0% micro/minerals mix 107 
[including 280 mg of monensin/animal/day and 90 mg of tylosin/animal/day (Elanco Animal 108 
 60 
 
Health, Greenfield, IN, USA)].  Standard operating procedures at the feedlot were followed for 109 
cattle management and care; sprinklers were used as needed to reduce heat stress risks.  Standard 110 
bunk management procedures of the feedlot were followed, which allowed feed to be available 111 
to cattle at all times.  Feedlot personnel who were responsible for bunk management were 112 
blinded to treatment allocation throughout the study.  Bunk calls were made each morning prior 113 
to feeding, and feed was added or taken away on a per head basis according to the bunk call to 114 
maintain a target amount of feed left in the bunk the next morning.  The Kansas State University 115 
Institutional Animal Care and Use Committee approved the study.   116 
 117 
 Intervention Period 118 
The intervention period of the study lasted an average of 86.6 days (range 84 – 88 d) as 119 
the allocation period for study blocks ranged from March 31 through May 14, 2011 and the end-120 
dates of the intervention period ranged between June 20 and August 3, 2011 (Cull et al., 2012).  121 
Feedlot personnel individually weighed all animals at the beginning and conclusion of the study 122 
while total feed delivered (dry matter basis) was weighed and recorded daily at the pen level.  123 
Feedlot personnel administering treatments were not the same personnel as those collecting 124 
health, feeding, and performance data throughout the study; daily health monitoring and 125 
performance collection followed standardized procedures of the feedlot.  Response variables of 126 
interest to evaluate live performance impacts during the study period were: cumulative dry 127 
matter intake (cDMI), daily dry matter intake (dDMI), cumulative ADG and G:F.  The DMI 128 
values were based on feed delivery records for the feedlot.  The dDMI was recorded 129 
continuously over the entire intervention period; however, we determined a priori to analyze 130 
these data in three different periods; the initial allocation, treatment and step-up feeding period (d 131 
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0 – 15); the re-vaccination period (d 16 – 30); and the final duration of the intervention period (d 132 
> 31).  The cumulative calculations for cDMI, ADG and G:F were computed on a pen-level basis 133 
at the end of the intervention period; however, dDMI was calculated for each pen daily.  134 
Calculations were:  135 
Mean cumulative DMI (cDMI) = total dry matter delivered to pen ÷ total head days (total 136 
number of animals within home pen x days on feed) 137 
Mean daily DMI (dDMI) = total dry matter delivered to pen ÷ total number of animals within 138 
the home pen on that day 139 
ADG = total weight gain for cattle finishing the intervention period (total out-weight–total 140 
in-weight) ÷ total head days for cattle finishing the intervention period  141 
G:F =  total weight gain (as defined above) ÷ total feed delivered (dry matter  142 
 weight delivered to the home pen) 143 
 144 
 Intervention to Harvest  145 
 Following the intervention period, a terminal sort program that targets carcass goals was 146 
followed.  Cattle were sorted and either shipped for harvest within the week, or re-allocated to 147 
pens based on their projected finishing time (using the feedlot’s confidential formula which 148 
includes data on weight, hip height, and other parameters).  All sorting was completed using a 149 
process completely independent of previous interventions (i.e. blinding to treatment groups).  150 
Cattle that were re-allocated for further finishing were not maintained in the initial pens based on 151 
the previous intervention assignment; however, all steers were individually identified with 152 
identity maintained through harvest, and all cattle (regardless of initial treatment group) were 153 
managed identically following resorting.  After the intervention period, the DFM was fed to all 154 
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cattle until harvest.  Cattle were sent to a commercial packing plant where all animals were 155 
humanely harvested and processed according to standardized procedures.  Individual carcasses 156 
were tracked by animal electronic identification tags and the plant’s carcass identification 157 
system.  Plant personnel collected individual carcass data including: HCW, yield grade, and 158 
quality grade.  Individual carcasses received yield grades of 1, 2, 3, 4 or 5 and quality grades of 159 
Prime, Choice, Certified Angus Beef, Select, Standard, Commercial, or Dark Cutter.  Other 160 
calculated response variables of interest included days on feed [DOF; enrollment date into the 161 
study (d 0) – harvest date] and enrollment weight/head [total pen weight at enrollment ÷ total 162 
head count at enrollment (pen level)]. Dressing percentage and live weight at harvest (and thus 163 
cumulative ADG from allocation until harvest) were not measured on an individual animal basis 164 
and thus were not utilized to evaluate potential treatment effects. 165 
 166 
 Data Analysis 167 
Pen-level general and generalized linear mixed models (LMM and GLMM, respectively; 168 
Proc Glimmix, SAS, Version 9.2, Cary, NC) were used to assess potential treatment effects on 169 
responses of interest.  Cattle performance (i.e. ADG, DMI, and G:F) data were modeled using 170 
LMM that assume a Gaussian distribution of the data.  Carcass yield grade and quality grade data 171 
were modeled using a GLMM with a cumulative link function and a proportional odds 172 
assumption (Osterstock et al., 2010) on the ordered categorical nature of the data.  A likelihood 173 
ratio test was used to evaluate the proportional odds assumption against a multinomial model 174 
fitted with a generalized logit link function of quality grade and yield grade data from harvest.  175 
For all LMM and GLMM models, the random effects of block (and block-by-treatment for 176 
GLMM) were fitted in order to recognize block as the clustering factor and pen as the 177 
 63 
 
experimental unit for treatment.  For dDMI data, additional random effects were used to account 178 
for repeated pen data over time (using a first order autoregressive term).  Fixed effects in the 179 
model included treatment effects (i.e. VAC and DFM) and time as appropriate for each response; 180 
further, all applicable 2- and 3-way interactions.  Model diagnostics were assessed based on 181 
studentized residuals (LMM) and functions of the maximum-likelihood based Pearson2 182 
statistics for overdispersion (GLMM).  Comparisons with P-values < 0.05 were considered 183 
statistically significant.  Treatment comparisons were based on tailor-built contrasts.  The Tukey-184 
Kramer or Bonferroni procedures, as appropriate in each case, were used to prevent inflation of 185 
Type I error due to multiple comparisons.  Kenward-Rogers' method was used to estimate 186 
degrees of freedom and make corresponding adjustments to estimated standard errors.  Estimated 187 
model-adjusted means (lsmeans; back transformed to original scale for GLMMs) and 188 
corresponding standard errors were reported.  189 
 190 
 Results 191 
In a previous study of this population of steers, Cull et al. (2012) reported no significant 192 
differences in mean pen size, mortality risk, or culling risk.  However, vaccination (but not DFM 193 
feeding) was found to significantly reduce E. coli O157:H7 fecal shedding.  Further, preliminary 194 
assessments of cattle performance (after removing mortalities and culled steers) indicated that 195 
DFM was associated with improved F:G during the intervention period and that vaccination was 196 
associated with poorer ADG and F:G during the intervention period (Cull et al., 2012).  197 
In this current study, we provided a much more in-depth assessment of cattle 198 
performance during the intervention period. More specifically, steer weights and performance 199 
indicators are reported separately and marginalized relative to each other for DFM (Table 1) and 200 
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VAC (Table 2), because no significant interactions between treatments were observed (P > 0.05).  201 
Overall mean enrollment weight was 377.6 kg (range 350.2 to 403.9 kg) with no significant 202 
differences among treatments.  Descriptive statistics on weight and performance indicators 203 
(mean; range) were: out-weight (534.3kg; 489 to 534.3kg), total gain (129.2 kg; 109.0 to 204 
144.3kg), cDMI (8.9 kg/h/d; 8.4 to 9.2kg/h/d), ADG (1.12 kg; 0.65 to 1.45kg), and G:F (1.27 x 205 
10-2; 0.70 x 10-2 to 1.62 x 10-2).  The out weight and cumulative DMI were significantly lower 206 
for VAC pens (Table 2), but no significant effect of DFM was observed for this response (Table 207 
1).  Total weight gain was significantly increased in pens fed the DFM (Table 1), whereas total 208 
gain was significantly lower in vaccinated pens as compared to those that were not vaccinated 209 
(Table 2).  Vaccinated pens (Table 2) had a significant reduction of ADG compared to non-210 
vaccinated pens, while DFM-fed pens (Table 1) had significantly increased G:F compared to 211 
non-DFM pens.  However, no evidence for any effects of DFM on ADG (Table 1) or of VAC on 212 
G:F were apparent (Table 2). 213 
The overall daily DMI means for the three study periods analyzed were: 8.26 kg/head/d 214 
for days 0 – 15, 8.64 kg/head/d for days 16 – 30 and 9.17 kg/head/d for days 31 – 85.  During the 215 
step-up and initial feeding period (d 0 – 15) there was no evidence of significant effects of 216 
treatment or treatment by time; however, time was significantly associated with dDMI (P < 217 
0.01).  For period 2 (d 16 – 30), there was a significant treatment by time interaction (P < 0.01).  218 
More specifically, vaccinated pens showed a temporary decrease in dDMI relative to those non-219 
vaccinated and this effect was apparent from 2 to 6 days following re-vaccination (i.e. days 23, 220 
24, 25, 26 and 27 of the study; Figure 1).  There was no evidence for any DFM effects (P = 0.94) 221 
during this study period.  For final feeding period (d 31 – 85), there was an effect of time (P < 222 
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0.01) on dDMI, but there was no evidence for effects of treatment (P=0.69) or a treatment by 223 
time (P=0.98) interaction.    224 
Of the initial study population (n=17,148 animals), 96.15% (n=16,488) were harvested, 225 
2.96% (n=508) died, 0.56% were culled (n=96) and 0.32% (n=56) were missing from the feedlot 226 
database.  Complete carcass data were available for 92.85% (15,309/16,488) of harvested steers, 227 
and an additional 1.95% (322/16,488) of the animals had data on HCW, yield grade, and quality 228 
grade.  The remaining 5.20% (857/16,488) of the animals were considered missing data as cattle 229 
were sent to harvest, but no carcass data were received.  Estimates of carcass performance are 230 
reported separately for DFM (Table 3) and VAC (Table 4), as no significant interactions were 231 
apparent for any of the corresponding outcomes (P > 0.05).  232 
At harvest, there were no significant effects of DFM or VAC on number of cattle 233 
harvested or enrollment weight (Tables 3 and 4).  However, vaccinated pens had increased DOF 234 
and HCW compared to non-vaccinated pens (Table 4).  Feeding the DFM during the intervention 235 
period had no significant effect on total DOF (Table 3).  Furthermore, pens fed the DFM during 236 
the intervention period had decreased HCW as compared to pens that were not fed the DFM 237 
during the intervention period (Table 3).   238 
Descriptive statistics on the count (percentage) of cattle in each quality and yield grade 239 
category are provided in Table 5.  There was no evidence for any effect of treatment on the 240 
distribution of response categories for quality grade (P = 0.63) and yield grade (P = 0.49). 241 
  242 
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 Discussion 243 
 The results from this study demonstrate that the live animal performance of commercial 244 
feedlot cattle was significantly affected by the use of the SRP vaccine and DFM products which 245 
were originally administered to evaluate their effects on fecal shedding of E. coli O157:H7.  In 246 
addition, the evaluations of these products during a relatively short-term intervention period 247 
(mean=86.6 d) resulted in subsequent differences in HCW despite the fact that all cattle were 248 
enrolled in a terminal sorting program after the intervention period and then were managed 249 
identically as they were fed for an average of approximately 80 additional days until harvest.  250 
Although the actual magnitude of the effects of the vaccine and DFM, as well as associated costs 251 
or financial benefits, may differ across production systems, this study demonstrated that impacts 252 
on production need to be considered when implementing pre-harvest interventions for food 253 
safety pathogens.  The need to consider both direct and indirect production costs or benefits 254 
associated with pre-harvest food safety programs has been discussed previously (Loneragan and 255 
Brashears, 2005; Thomson et al., 2009; Cull et al., 2012), but this study is the most 256 
comprehensive assessment of live and carcass performance outcomes following interventions in 257 
commercial feedlot cattle.  258 
 The current study is a continuum from a previous study demonstrating that a two dose 259 
regimen of the commercially available SRP vaccine in large commercial feedlot pens yielded a 260 
significant reduction in E. coli O157:H7 shedding, but also had a potentially negative impact on 261 
cattle weight gains (Cull et al., 2012).  However, that study used relatively unique performance 262 
formulae, did not evaluate live or carcass performance impacts in detail, and found no evidence 263 
for vaccine-associated differences in feed conversions.  Feed conversions over the same time 264 
period for the same data were significantly different in this current study; the discrepancy 265 
 67 
 
between the previous and current studies can be attributed to calculation differences as the 266 
previous study utilized the production systems’ formula that added the estimated body weight of 267 
cattle that died or were culled during the study intervention period (Cull et al., 2012).  In turn, the 268 
current study utilized the total measured cattle weight for each pen at both study initiation and at 269 
the end of the intervention period (i.e. pen in-weight to pen out-weight). 270 
In the current study, the performance effects that were observed from study initiation to 271 
harvest indicated significant increases in DOF, by approximately 3 days, for vaccinated pens 272 
which is likely associated with the significantly larger HCW in vaccinated pens.  Although 273 
previous studies with this vaccine have reported no evidence for any vaccination effects in pen-274 
level cattle performance (Thomson et al., 2009; Fox et al., 2009; Thornton et al., 2009; Rezac et 275 
al., 2012), there were critically different study design features in the current versus previous 276 
studies.  In previous studies, both vaccinated and control pens were handled at re-vaccination and 277 
controls were given a placebo.  While this practice is common for research protocols, it is not 278 
necessarily representative of commercial scenarios.  Additionally, those studies had half as many 279 
pens (20), multiple feedlot sites (Rezac et al., 2012) and much fewer animals overall (< 5,000) 280 
compared to the current study.  281 
 To our knowledge, this is the first published study to report a difference in DMI and other 282 
performance indicators between vaccinated (two dose regimen of SRP vaccine) and non-283 
vaccinated pens that were neither handled nor given a placebo at re-vaccination.  The significant 284 
difference in DMI for vaccinated pens during the re-vaccination period (d 16 – 30), more 285 
specifically for the days immediately following revaccination (Figure 1), may be attributed to the 286 
biological response associated with the vaccine and/or the effects of handling cattle for 287 
revaccination.  Although previous studies with this vaccine have demonstrated no evidence for 288 
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differences in cattle DMI or performance (Thomson et al., 2009; Fox et al., 2009; Thornton et al., 289 
2009; Rezac et al., 2012), decreased performance effects associated with vaccination have been 290 
reported in studies of clostridial vaccines; where injection location and type of vaccine have been 291 
associated with reductions in animal performance (Chirase et al., 2001).  Previous studies, 292 
unrelated to vaccination, also have reported a decrease in DMI when comparing handled cattle to 293 
non-handled controls (Voisinet et al., 1997; Franisco et al., 2012), as well as an increased stress 294 
response and temperament differences in handled cattle (Grandin, 1997).  Although we 295 
demonstrated a difference in DMI and related performance indicators, the specific reason for the 296 
effect (i.e. vaccine response versus handling) cannot be determined in our study due to the study 297 
design.  Indeed, an additional control group that was re-handled and given a placebo would have 298 
been needed to sort out the effect of vaccination from that of handling.  Regardless of 299 
mechanism, the rationale for the experimental design on our current study is based on 300 
management practices that are representative of commercial feedlot settings, whereby handling 301 
alone, without any revaccination, would not be likely in the case that a vaccination program was 302 
implemented.  For such a commercial setting, our data indicate the potential for negative effects 303 
of handling and vaccination on cattle performance. 304 
 The use of direct-fed microbials, particularly strains of Lactobacillus acidophilus, has 305 
become a relatively common practice in the cattle feeding industry (NAHMS, 2013).  While 306 
many potential positive benefits have been described, effects on live cattle or carcass 307 
performance have not been demonstrated on a consistent basis across different commercial 308 
feedlot settings.  The commercial low-dose Bovamine product (106 CFU/head/d of Lactobacillus 309 
NP51) was utilized in the current study because of the perception that this product can improve 310 
cattle performance while reducing fecal shedding of E. coli O157:H7 (Loneragan and Brashears, 311 
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2005; Cull et al., 2012).  Pens receiving the DFM during the intervention period had a significant 312 
increase in total gain and G:F, which is in agreement with multiple other studies (Rust et al., 313 
2000; Vasconcelos et al., 2008; Hanford et al., 2011).  In contrast, other studies have found no 314 
significant differences associated with DFM feeding (Brashears et al., 2003; Younts-Dahl et al., 315 
2005; Peterson et al., 2007).  In the current study, pens fed, versus those not fed the DFM during 316 
the intervention period had significantly lower HCW at harvest; however, it is worth noting that 317 
all pens were fed the DFM after the intervention period.  Some previous DFM studies have 318 
reported no significant differences in HCW (Rust et al., 2000; Elam et al., 2003) while other 319 
primary studies and a meta-analysis demonstrated increased HCW (Galyean et al., 2000; 320 
Peterson et al., 2007; Hanford et al., 2011).  Finally, our study and others reported no evidence 321 
for a significant difference in ADG relative to DFM feeding (Elam et al., 2003; Peterson et al., 322 
2007), while other previous studies demonstrated an increase in ADG (Ware et al., 1988; 323 
Swinney-Floyd et al., 1999; Hanford et al., 2011).  Some of these seemingly contradictory results 324 
are likely due to important differences among studies in their study design, statistical power, pen 325 
size, feeding period, diet, cattle type, or product dose.  Further, DFM strains have differed among 326 
studies with some using strain NP51 (Elam, 2003 et al.; Younts-Dahl et al., 2005; Peterson et al., 327 
2007; Hanford et al., 2011; Cull et al., 2012) and others using strain NP45 (Rust et al., 2000) or a 328 
combination of NP51 and NP45 (Vasconcelos et al., 2008).  In addition, our study is unique as 329 
the DFM was fed or not fed to half the pens during the intervention period, but all cattle 330 
remaining on feed following the post-intervention period terminal sort were fed the DFM until 331 
harvest.  332 
 The distributions of carcass quality and yield grades were typical for the type of steers 333 
and production management system (Table 5) and were in agreement with results from other 334 
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studies on the DFM (Swinney-Flyod et al., 1999; Galyean et al., 2000; Elam et al., 2003) and the 335 
SRP vaccine (Rezac et al., 2012) in which no significant treatment effects were observed.  It is 336 
perhaps not surprising that the distributions of quality and yield grades were not significantly 337 
different amongst treatments given the management and terminal sort program of the production 338 
system and the goal to target common carcass end-points from all individual animals regardless 339 
of their prior history. 340 
  Based on the collective results of this study, we conclude that the use of these direct-fed 341 
microbial and vaccine products have differential and independent effects on cattle performance 342 
and carcass characteristics in a commercial feedlot setting.  The re-vaccination process resulted 343 
in a temporary but significant decrease in DMI, which likely led to the lower weight gains for 344 
vaccinated cattle during the intervention period, and the subsequent increase in DOF until 345 
harvest.  The negative impact of utilizing this vaccine on cattle performance, from vaccine 346 
administration through harvest, had not been demonstrated previously.  Although the actual costs 347 
of vaccination were not estimated for this study, a recently published paper estimated direct costs 348 
to producers of $8.35/hd to $14.99/hd depending on whether there were cattle performance 349 
effects of vaccination or not (Tonsor and Schroeder, 2015).  Interestingly, these authors showed 350 
that if a pre-harvest E. coli vaccine led to reduction of retail or packer costs of 1.2% to 3.9%, 351 
producers would be economically neutral to adoption (Tonsor and Schroeder, 2015).  Feeding 352 
the DFM increased total weight gain and improved feed conversion during the intervention 353 
period, though these positive attributes were not reflected at harvest. However, all cattle were fed 354 
the DFM following the terminal sort that took place after the intervention period.  We 355 
acknowledge that the observed magnitude of the intervention effects may differ among 356 
production systems, particularly when cattle types, feeding programs, and other management 357 
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attributes differ.  However, it is clear that further insight into the effects of pre-harvest food 358 
safety pathogen control programs on cattle performance is warranted due to potential financial 359 
implications for program adoption in the industry.  360 
 361 
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Table 3.1 Model estimated1 means, standard errors, and corresponding P-values for pair-wise comparisons of performance 454 
data during the intervention period for study pens that received, or did not receive, the direct-fed microbial (DFM)2 455 
 Treatment  
Item Fed DFM No-DFM P-value 
Cattle (pens)      8,575 (20)      8,573 (20) - 
Enrollment weight/head, kg (SE) 377.25 (4.98)  377.87 (4.98) 0.06 
Out-weight/head, kg (SE) 507.78 (4.51) 505.78 (4.51) 0.11 
Total Gain/head, kg (SE) 130.53 (2.67)      127.91 (2.67) 0.03 
DMI, kg/h/d (SE)     8.85 (0.06)     8.87 (0.06) 0.55 
ADG, kg (SE)     1.43 (0.03) 1.40 (0.03) 0.13 
Gain:Feed (SE) (x10-1)       1.61 (0.02) 1.57 (0.02) 0.05 
 456 
1 Least square mean estimates for marginal means of DFM  457 
2Bovamine (106 CFU/animal/day of Lactobacillus acidophilus and 109 CFU/animal/day of Propionibacterium freudenreichii), 458 
Nutrition Physiology Corp., Guymon, OK, USA 459 
  460 
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Table 3.2 Model estimated1 means, standard errors, and corresponding P-values for pair-wise comparisons of performance 461 
data during the intervention for study pens that received, or did not receive, the vaccine2 462 
 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
1 Least square mean estimates for marginal means of vaccination 471 
2E. coli SRP vaccine, Zoetis Animal Health, New York, NY, USA 472 
 473 
  474 
 475 
 476 
 477 
 478 
 Treatment  
Item Vaccinated Non-Vaccinated P-value 
Cattle (pens)       8,575 (20)     8,573 (20) - 
Enrollment weight/head, kg (SE) 377.52 (4.98) 377.59 (4.98) 0.82 
Out-weight/head, kg (SE) 505.02 (4.51) 508.54 (4.51)           < 0.01 
Total Gain/head, kg (SE) 127.50 (2.67) 130.94 (2.67)           < 0.01 
DMI, kg/h/d (SE) 8.79 (0.06) 8.93 (0.06)           < 0.01 
ADG, kg (SE) 1.39 (0.03) 1.43 (0.03) 0.03 
Gain:Feed (SE) (x10-1)   1.58 (0.02) 1.60 (0.02) 0.30 
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Figure 3.1 Model estimated1 means for daily DMI during the period (d 16 – 30) when the pens were, or were not, given the 479 
second dose of the vaccine2. Re-vaccination occurred on day 21 represented by the star symbol ( ).  Means for days 23, 24, 480 
25, 26 and 27 were significantly different (P < 0.05) between groups as indicated by an asterisk (*).  The lower standard error 481 
bars for vaccinated and upper standard error bars for non-vaccinated pens are displayed.       482 
 483 
 484 
  485 
0
1
2
3
4
5
6
7
8
9
10
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
m
ea
n
 D
M
I 
(k
g
) 
/h
ea
d
Days 
Non-vaccinated
Vaccinated
*     *      *      *       * 
 79 
 
Table 3.3 Model estimated1 means, standard errors, and corresponding P-values for pair-wise comparisons of performance 486 
data for the intervention to harvest period for cattle that received, or did not receive, the direct-fed microbial (DFM)2 during 487 
the intervention period. 488 
  Treatment  
Item Population  Fed DFM No-DFM P-value 
   (during intervention period)3  
Days on Feed (SE) N = 16,203  165.03 (4.10) 166.26 (4.10) 0.16 
Enrollment weight, kg (SE) N = 16,488  395.42 (5.14) 395.96 (5.14) 0.14 
HCW, kg (SE) N = 15,631  408.00 (1.41) 409.50 (1.41) < 0.01 
 489 
1 Least square mean estimates for marginal means of DFM  490 
2Bovamine (106 CFU/animal/day of Lactobacillus acidophilus and 109 CFU/animal/day of Propionibacterium freudenreichii), 491 
Nutrition Physiology Corp., Guymon, OK, USA) 492 
3Cattle that were re-allocated for further finishing following the intervention period were not maintained in the initial pens based on 493 
the previous intervention assignment; however, all steers were individually identified with identity maintained through harvest, and all 494 
cattle (regardless of initial treatment group) were fed DFM and managed identically following resorting through harvest.   495 
 496 
  497 
 80 
 
Table 3.4 Model estimated1 means, standard errors, and corresponding P-values for pair-wise comparisons of performance 498 
data for the intervention to harvest period for cattle that received, or did not receive, the vaccine2 499 
  Treatment  
Item Population  Vaccinated Non-Vaccinated P-value 
Days on feed (SE) N = 16,203  167.23 (4.10) 164.07 (4.10) < 0.01 
Enrollment weight, kg (SE) N = 16,488  395.64 (5.14) 395.74 (5.14) 0.77 
HCW, kg (SE) N = 15,631  409.49 (1.41) 408.10 (1.41) 0.01 
 500 
1 Least square mean estimates for marginal means of vaccination 501 
2E. coli SRP vaccine, Zoetis Animal Health, New York, NY, USA 502 
  503 
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Table 3.5 Descriptive statistics on the count (percentage) of cattle in each quality and yield grade category by treatment group; 504 
there was no evidence of treatment effects during the intervention period on quality grade (P = 0.63) or yield grade (P = 0.49) 505 
at harvest.   506 
  Treatment 
Item Population (Pen) Control VAC DFM VAC+DFM 
Quality Grade N = 15,631 (40)     
Prime (%)  41 (1.0) 36 (0.9) 31 (0.8) 47 (1.2) 
CAB - Choice (%)  2338 (59.2) 2272 (57.9) 2252 (58.0) 2223 (57.4) 
Select (%)  1314 (33.2) 1381 (35.2) 1372 (35.3) 1357 (35.1) 
Standard (%)  160 (4.0) 146 (3.7) 145 (3.7) 149 (3.8) 
Outs (%)3  101 (2.6) 89 (2.3) 82 (2.2) 95 (2.5) 
Total  3954 (100.0) 3924 (100.0) 3882 (100.0) 3871 (100.0) 
      
Yield Grade N = 15,631 (40)     
1 (%)  747 (18.9) 744 (19.0) 710 (18.3) 714 (18.4) 
2 (%)  1553 (39.2) 1617 (41.2) 1590 (41.0) 1574 (40.7) 
3 (%)  1304 (33.0) 1239 (31.6) 1263 (32.5) 1275 (32.9) 
4 (%)  312 (7.9) 298 (7.5) 295 (7.6) 281 (7.3) 
5 (%)  38 (1.0) 26 (0.7) 24 (0.6) 27 (0.7) 
Total  3954 (100.0) 3924 (100.0) 3882 (100.0) 3871 (100.0) 
1E. coli SRP vaccine (VAC), Zoetis Animal Health, New York, NY, USA 507 
2Bovamine (DFM; 106 CFU/animal/day of Lactobacillus acidophilus and 109 CFU/animal/day of Propionibacterium freudenreichii), Nutrition 508 
Physiology Corp., Guymon, OK, USA) 509 
3Outs included individual carcasses that received a quality grade of Commercial, Standard or Dark Cutter 510 
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Chapter 4 - Feedlot- and pen-level prevalence of Enterohemorrhagic 511 
Escherichia coli in feces of commercial feedlot cattle in two major 512 
U.S. cattle feeding areas 513 
 514 
 Abstract 515 
The objective of the study was to determine feedlot- and pen-level fecal prevalence of 516 
seven Enterohemorrhagic Escherichia coli (EHEC) serogroups (O26, O45, O103, O111, O121, 517 
O145, and O157, or EHEC-7) and their associated virulence genes (stx1, stx2, and eae) in feces 518 
of commercial feedlot cattle in two feeding areas in United States.  Cattle pens from four 519 
commercial feedlots in each of the two major cattle feeding areas, study areas A and B, were 520 
sampled.  Up to 16 pen-floor fecal samples were collected from each of 4 to 6 pens per feedlot, 521 
per monthly visit, for a total of three visits from June to August, 2014.  Culture-based procedures 522 
including fecal enrichment in E. coli broth, immunomagnetic separation with individual beads 523 
for O157 and two sets of pooled beads for the six non-O157 serogroups, and plating on selective 524 
medium, followed by molecular-based detection methods for EHEC confirmation were 525 
conducted.  Generalized linear mixed models were fitted to estimate feedlot-, pen-, and sample-526 
level fecal prevalence of EHEC-7 and to evaluate associations between potential demographic 527 
and management risk factors with feedlot prevalence of EHEC-7.  All study feedlots and 31.0% 528 
of the study pens had at least one fecal sample that tested positive for non-O157 EHEC, whereas 529 
61.9% of pens tested positive for EHEC O157; sample-level prevalence estimates ranged from 530 
0.0% for EHEC O121 to 18.7% for EHEC O157.  Within-pen prevalence of EHEC O157 varied 531 
significantly by month of sampling; similarly within-pen prevalence of non-O157 EHEC varied 532 
significantly by month as well as by the sex composition of the pen (i.e., heifer, steer or mixed). 533 
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Feedlot management factors, however, were not significantly associated with fecal prevalence of 534 
EHEC-7 serogroups. Intraclass correlation coefficients for EHEC-7 models indicated that most 535 
of the variation occurred between pens, rather than within pens, or between feedlots.   Hence, the 536 
potential combination of pre-harvest interventions and pen-level management strategies (e.g., sex 537 
segregation/exclusion) may have positive food safety impacts downstream along the beef chain. 538 
 539 
 Introduction 540 
For the past three decades, studies of Shiga toxin-producing Escherichia coli (STEC) in 541 
commercial feedlot systems have focused primarily on E. coli O157:H7 (STEC O157), despite 542 
the fact that non-O157 STEC are estimated to cause twice as many human illnesses (e.g., 543 
diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome) in the United States (Scallan et 544 
al., 2011).  In fact, it has been estimated that STEC O26, O45, O103, O111, O121, and O145 545 
(non-O157 STEC) represented 83% of the confirmed non-O157 STEC human infections from 546 
2000 to 2010 (Gould et al., 2013).  Although a variety of food commodities (e.g., leafy 547 
vegetables, game meat, beef, dairy, pork, and fruits or nuts) are linked to these non-O157 STEC 548 
outbreaks and human infections (Luna-Gierke et al., 2014), cattle are recognized as the primary 549 
reservoir for STEC and intermittently shed these bacteria in their feces (CDC, 2014; USDA-550 
FSIS, 2014).  As a result, the fecal to hide to carcass pathway (i.e., contamination pathway) 551 
provides a unique opportunity for STEC transfer with the potential for contamination of beef and 552 
other food products during the harvest process (Ferens and Hovde, 2011; Painter et al., 2013).  In 553 
addition to the major public health concerns, the economic impact of STEC on the beef industry 554 
has been profound (NCBA, 2012); indicating the need for effective pre- and post-harvest 555 
interventions against STEC-7 pathogens along the beef system.  556 
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Although the majority of research has focused on STEC O157, there is a growing body of 557 
scientific literature on the effects of non-O157 STEC colonization, prevalence, and transmission 558 
in commercial feedlot operations.  Shiga toxin-producing E. coli are characterized by the 559 
presence of an O antigen and Shiga toxin virulence genes (stx1 and/or stx2).  Enterohemorrhagic 560 
Escherichia coli or EHEC, are a subset of STEC that also possess the intimin gene (eae).  561 
Recently, published literature has reported wide prevalence estimates of non-O157 STEC and 562 
EHEC, ranging from 0.0 to 16.9% and 0.0 to 10.5%, respectively, in cattle feces (Cernicchiaro et 563 
al., 2013 and 2014; Baltasar et al., 2014; Ekiri et al., 2014; Paddock et al., 2014; Dewsbury et al., 564 
2015).  However, these studies were limited to reporting prevalence estimates of non-O157 565 
STEC from range cattle or feedlot cattle in a single operation.  Although one study indicated a 566 
high pen to pen variability of non-O157 STEC shedding in cattle feces (Dewsbury et al., 2015), 567 
additional studies are needed for effective interventions to reduce the fecal load non-O157 STEC 568 
in cohorts of cattle.  Processors have successfully applied post-harvest interventions to hides and 569 
carcasses towards significantly reducing foodborne pathogens in beef.  Understanding sources of 570 
variability and drivers of STEC shedding in cattle production environments will help the 571 
identification and implementation of needed pre-harvest approaches.  The objective of this study 572 
was to determine the feedlot- and pen-level prevalence of seven serogroups of EHEC (O26, O45, 573 
O103, O111, O121, O145 and O157) and their associated virulence genes (stx1, stx2, and eae) in 574 
feces of commercial feedlot cattle in two major cattle feeding areas of the United States. 575 
 576 
 Materials and Methods 577 
 Study population and sampling  578 
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Samples were collected from eight commercial feedlot operations in two major U.S. 579 
cattle feeding areas from June to August, 2014.  Cattle were managed following standard 580 
operating procedures of the respective study feedlot operations.  This observational study 581 
followed a repeated cross-sectional design. Study area A consisted of four feedlots within a 150-582 
mile area in northwest Texas, whereas study area B consisted of four feedlots within a 100-mile 583 
area in central Nebraska. Feedlot eligibility criteria were determined based on: close proximity 584 
(within 150 miles of each other within each area) to study areas (A and B), having cattle on a 585 
finishing diet during the summer months, and willingness to complete a questionnaire to gather 586 
demographic and management data in each visit.  A priori sample size estimates were generated 587 
by data simulation and power calculations; assumptions included: 10% prevalence of EHEC 588 
O157 and differences of up to 5% prevalence of non-O157 EHEC between pens, 20% Type II 589 
error and 5% Type I error.  Feedlots were visited once per month for three months (three visits 590 
per feedlot). Up to 16 pen-floor fecal samples from each of four to six pens per feedlot, per visit, 591 
were obtained.  Samples (~30 g) of freshly defecated individual fecal pats were collected from 592 
multiple areas throughout the pen; care was taken to avoid ground contamination.  Each week, 593 
the total number of pens sampled was determined based on the availability of pre-harvest pens 594 
(approximately two weeks before cattle were harvested) within each feedlot, as pens were not re-595 
sampled throughout the study.  Samples were placed in sterile bags and transported on ice packs 596 
to the Pre-harvest Food Safety Laboratory (College of Veterinary Medicine, Kansas State 597 
University, in Manhattan, Kansas) where they were refrigerated (4°C) for 14-16 h, followed by 598 
processing and testing. 599 
 600 
 Laboratory protocols for detection of EHEC 601 
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Approximately 2 g of feces were mixed into 18 mL of E. coli broth (EC; Difco, 602 
ThermoFisher, Waltham, MA) and incubated at 40°C for 6 h (Paddock et al., 2012).  A 980-µL 603 
sample of enriched fecal suspension was subjected to an immunomagnetic separation (IMS) 604 
procedure using Abraxis® beads (Abraxis LLC, Warminster, PA).  The IMS procedure consisted 605 
of three separate IMS runs, one for individual O157 beads and two using separate sets of pooled 606 
non-O157 serogroup beads with pools including the following serogroups: 1) O26, O45, and 607 
O111, and 2) O103, O121, and O145 serogroup beads (Noll et al., 2016).  A 50-µL aliquot of the 608 
O157 bead suspension was spread-plated onto sorbitol MacConkey agar with cefixime (0.05 609 
mg/L) and potassium tellurite (2.5 mg/L) (CT-SMAC; Bai et al., 2010), and 50 µL of bead 610 
suspension for pooled non-O157 serogroups was spread-plated onto a modified chromogenic 611 
Possé medium (MP; Possé et al., 2008; Noll et al., 2016) for each of the two pooled procedures.  612 
Plates were incubated for 20-24 h at 37°C.  Six sorbitol-negative colonies from CT-SMAC and 613 
10 chromogenic colonies from each MP plate were randomly picked and individually streaked 614 
onto blood agar plates, then incubated for 18-24 h at 37°C.  Isolates obtained from CT-SMAC 615 
plates were tested for the presence of the O157 antigen using latex agglutination (Oxoid Ltd., 616 
Basingstoke, UK); if positive, isolates were then tested for indole production.  Confirmation of 617 
EHEC O157 isolates included a 6-gene multiplex PCR assay for identification of the rfbE 618 
(O157), eae (intimin), stx1 (Shiga toxin 1), stx2 (Shiga toxin 2), ehxA (hemolysin), and fliC (H7) 619 
genes (Bai et al., 2010).  Ten isolates from each non-O157 IMS procedure were pooled and 620 
tested by an 11-gene multiplex PCR assay that detects seven serogroups (O26, O45, O103, 621 
O111, O121, O145, and O157) and four major virulence genes (stx1, stx2, eae, and ehxA) as a 622 
screening procedure (Bai et al., 2012).  If pooled colonies were positive for an O serogroup and 623 
stx gene, then each isolate (total of 10 isolates/MP plate) was subjected to an additional 11-gene 624 
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multiplex PCR assay to confirm the presence of O serogroup and virulence genes at the colony 625 
level.  A sample was defined as EHEC positive if at least one individual colony tested positive 626 
for an O serogroup, stx gene (stx1 and/or stx2), and eae gene. 627 
 628 
 Questionnaire 629 
A questionnaire was pre-tested in four of the eligible feedlot managers prior to the start of 630 
the study.  Modifications to the questionnaire were made based on their feedback to eliminate 631 
confusing or misleading questions.   632 
 The questionnaire was written in English and consisted of open-ended (e.g., fill in the 633 
blank) and closed-ended (e.g., multiple choice) questions to obtain information on demographic 634 
and management variables at the feedlot- and pen-levels.  The questionnaire was administered in 635 
person to feedlot managers at the time of each sampling visit.  Information collected on 636 
demographic and management factors at the feedlot-level included: distillers percentage (ration 637 
percentage of distillers: <10%, 10-30%, and >30% on an as-fed basis), feedlot capacity (number 638 
of animals per feedlot), implementation of pre-harvest interventions (yes or no, name of the 639 
product(s), and dose), and manure storage management (on site: pen-floor fecal material stored 640 
at the feedlot, or off site: pen-floor fecal material stored outside the feedlot).  Information 641 
gathered on demographic factors at the pen-level included: days on feed (DOF), sex composition 642 
of the pen (heifers, steers, or both), pen size (number of animals per pen), sampling month (June, 643 
July, or August), and type of fed cattle (beef, dairy, or both).    644 
 645 
 Statistical analysis  646 
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Proportion positives for E. coli and EHEC O serogroups were calculated at the sample-647 
level, across all pens, as the number of samples that tested positive for an E. coli O serogroup 648 
(O26, O45, O103, O121, O145, and O157) and EHEC serogroup (O serogroup and stx1 and/or 649 
stx2 and eae) divided by the total number of samples collected. Cumulative pen- and feedlot-650 
level percent positives were calculated as the number of pens or feedlots that had at least one 651 
positive sample for each EHEC serogroup of interest, divided by the total number of pens or 652 
feedlots, respectively. 653 
 Model-adjusted cumulative within-pen prevalence estimates and their 95% confidence 654 
intervals were evaluated from model intercepts via generalized linear mixed models (GLMMs) 655 
that included random effects of sampling week and feedlot within study area.  Outcome 656 
variables, modeled using a binomial distribution, were modeled as the number of test-positive 657 
samples within each pen divided by the number of samples collected per pen.  Independent 658 
models were fitted for each of the seven EHEC serogroups, and for all non-O157 EHEC.  Fixed 659 
effects for feedlot and study area were added, in independent models, to estimate mean within-660 
pen prevalence of each of the EHEC-7 serogroups in each of the study feedlots and study areas: 661 
random effects for sampling week or feedlot were included, respectively.  Models were fitted 662 
using Proc Glimmix (SAS Version 9.3, SAS Institute Inc., Cary, NC) using a logit link function, 663 
restricted pseudo-likelihood estimation, and Kenward-Rogers degrees of freedom approximation.   664 
Similar GLMMs were used to determine associations between potential risk factors (pen- 665 
and feedlot-level factors) with the within-pen or within-feedlot fecal prevalence of EHEC.  666 
Initially, all independent variables were examined in a univariable screen. Independent variables 667 
included into the univariable screening included: DOF (<100, 100-200, 200-300, and >300 days 668 
on feed/pen), sex of the pen (heifer, steer, or both), pen size (<100, 100-200, 200-300, and >300 669 
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animals/pen), sampling month (June, July, and August), and type of fed cattle (beef and dairy) at 670 
the pen level. Feedlot-level explanatory variables tested included: use of a direct-fed microbial 671 
(yes vs. no), ration percentage of distiller’s (<10%, 10-30%, and >30%), feedlot capacity (< 672 
25,000 and > 25,000 animals), and manure storage management (on site or off site).  The 673 
linearity assumption between continuous predictors and the outcome (on a logit scale) was 674 
assessed graphically.  If there was evidence of non-linearity, independent variables were 675 
categorized based on quartiles (Dohoo et al., 2009).  The Spearman’s rank correlation statistic 676 
was used to identify possible collinearity between variables; if the value of the correlation was 677 
greater than |0.8|, then only one of the variables was selected for inclusion in the multivariable 678 
model (Dohoo et al., 2009).  All independent variables that were significantly associated with the 679 
outcome at P < 0.20 were considered for inclusion in a main effects model. These variables were 680 
then fitted in a multivariable model where a manual backward elimination procedure was 681 
conducted until only statistically significant (P < 0.05) variables and confounders were kept. 682 
Model diagnostics were assessed based upon visual examination of best linear unbiased 683 
predictors and residual plots.  The Tukey-Kramer procedure was used to prevent inflation of 684 
Type I error due to multiple comparisons.  Model-adjusted means and corresponding 95% 685 
confidence intervals were reported.  686 
Covariance parameters estimates for pen and feedlot were evaluated from model 687 
intercepts via GLMMs.  The outcome variables included the number of samples that tested 688 
positive for EHEC O157 or for all non-O157 EHEC serogroups, in independent models.  Non-689 
O157 EHEC were collapsed due to problems of convergence due to the small number of 690 
positives for some of the non-O157 EHEC serogroups.  Intraclass correlation coefficients (ICC) 691 
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for EHEC O157 and non-O157 EHEC were computed for pens and feedlots (Dohoo et al., 2009), 692 
and calculated using the latent variable technique (Dohoo et al., 2009) as follows:  693 
 694 
𝐼𝐶𝐶 𝑓𝑜𝑟 𝑐𝑎𝑡𝑡𝑙𝑒 𝑤𝑖𝑡ℎ𝑖𝑛 𝑎 𝑝𝑒𝑛 =  
𝜎𝑝
2
𝜎𝑝2 +  𝜎𝑓
2 +  𝜋2/3 
 695 
𝐼𝐶𝐶 𝑓𝑜𝑟 𝑐𝑎𝑡𝑡𝑙𝑒 𝑝𝑒𝑛𝑠 𝑤𝑖𝑡ℎ𝑖𝑛 𝑎 𝑓𝑒𝑒𝑑𝑙𝑜𝑡 =  
𝜎𝑓
2
𝜎𝑝2 + 𝜎𝑓
2 +  𝜋2/3 
 696 
 697 
where 𝜎𝑝
2 corresponds to the variance component for pen, 𝜎𝑓
2 the variance component for feedlot, 698 
and π2/3 corresponds to the value at which the error variance is fixed (Dohoo et al., 2009). 699 
 700 
 Results 701 
 Study population and sample collection 702 
The overall feedlot capacity and pen size of the study feedlots ranged from 8,000 to 703 
85,000 animals and 30 to 582 cattle/pen, respectively (Table 1).  Most of the study feedlots fed 704 
beef cattle only (n = 5), one fed cull dairy only, and two fed both beef and dairy cattle. Seventy-705 
five percent (95/126) of the study pens consisted of fed beef and 24.6% (31/126) fed dairy cattle.  706 
The number of days on feed of cattle in the study pens ranged from 11 to 382 days (Table 1).  707 
Cattle were fed a corn based finishing diet, representing 34 to 65% of the as-fed ration, with 708 
87.5% (7/8) of the feedlots utilizing a wet distiller’s grain within their ration.  Direct fed 709 
microbials were fed to cattle, from arrival to harvest, in 75% (6/8) of the feedlots (Table 1).  Pre-710 
harvest food safety vaccines for E. coli were not used in any of the study feedlots.   711 
A total of 1,886 samples were collected from a total of 126 pens (62 pens from study area 712 
A and 64 pens from study area B) in 8 feedlots (4 feedlots in each of the study areas) between 713 
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June and August, 2014.  Of the total number of samples (n = 1,886), 100% (1,886) of samples 714 
that were tested for non-O157 EHEC and 73.9% (1,393) of samples that were tested for EHEC 715 
O157 were included in the analysis.  The remaining 26.1% (493) of samples, including one entire 716 
pen, that were tested for EHEC O157, were not utilized in the analysis due to extensive microbial 717 
overgrowth on the media plates that rendered them unreadable.   718 
 719 
 Sample-level percent positives for E. coli O serogroups and EHEC 720 
Out of the total number of fecal samples, 20.4% (384/1,886) tested positive for at least 721 
one of the six non-O157 serogroups.  Serogroup-specific proportion of positives are as follows: 722 
4.6% (86/1,886) for O26, 4.7% (88/1,886) for O45, 14.1% (266/1,886) for O103, 0.4% (7/1,886) 723 
for O111, 1.8% (34/1,886) for O121, and 1.3% (25/1,886) for O145.  Overall, EHEC O157 was 724 
the most frequently isolated EHEC serogroup (18.7%) whereas fewer samples (3.3%) tested 725 
positive for non-O157 EHEC (Table 2).  Among EHEC O157 positive samples, 0.0% (0/260), 726 
56.5% (147/260), and 43.5% (113/260) tested positive for stx1, stx2, and both stx1 and stx2, 727 
respectively, while for non-O157 EHEC test-positive samples 79.4% (50/63), 11.1% (7/63), and 728 
9.5% (6/63) tested positive for stx1, stx2, and both stx1 and stx2 virulence genes, respectively. 729 
 730 
 Crude and model-adjusted pen-level prevalence  731 
At the pen-level, 61.9% (78/125) and 31.0% (39/126) of the pens had at least one sample 732 
testing positive for EHEC O157 and non-O157 EHEC, respectively (Table 2).  The crude 733 
cumulative prevalence varied greatly between pens. More specifically, the percentage of positive 734 
samples within a pen ranged from 0.0 to 12.5% for EHEC O26, 0.0 to 6.5% for EHEC O45, 0.0 735 
to 68.7% for EHEC O103, 0.0 to 33.3% for EHEC O111, 0.0 to 0.0% for EHEC O121, 0.0 to 736 
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41.7% for EHEC O145, and 0.0 to 83.3% for EHEC O157.  Cumulative model-adjusted (95% 737 
confidence intervals) within-pen prevalence estimates of EHEC serogroups were as follows: 738 
0.1% (0.0 - 4.5%) for EHEC O26, 0.1% (0.0 - 4.5%) for EHEC O45, 1.5% (0.0 - 4.5%) for 739 
EHEC O103, 0.1% (0.0 - 5.6%) for EHEC O111, 0.0% (0.0 - 0.0%) for EHEC O121, 0.5% (0.0 - 740 
3.8%) for EHEC O145, and 17.2% (14.5 - 19.9%) for O157 (Figure 1).   741 
 742 
 Crude and model-adjusted feedlot-level prevalence 743 
All study feedlots (n = 8) had at least one fecal sample testing positive for EHEC O157 or 744 
non-O157 EHEC.  EHEC serogroup-specific crude prevalence percentages are as follows: 0.0% 745 
for EHEC O121; 25.0% for EHEC O26, O45, and O111; 62.5% for EHEC O145; and 100.0% 746 
for EHEC O103 and O157 (Table 2).  Model-adjusted mean within-pen prevalence estimates for 747 
EHEC O157 varied significantly (P < 0.01) by feedlot; however, no significant differences (P > 748 
0.05) were observed for prevalence of non-O157 EHEC serogroups among feedlots (Table 3). 749 
 750 
 Crude and model-adjusted study area prevalence 751 
Each study area had at least one fecal sample testing positive for EHEC O157 or non-752 
O157 EHEC.  Cumulative model-adjusted (95% confidence intervals) within-pen prevalence 753 
estimates by study area are as follows: 16.2% (9.1 - 27.2%) for EHEC O157 and 2.7% (1.2 - 754 
6.1%) for non-O157 EHEC in study area A, whereas study area B prevalence estimates were 755 
18.5% (10.6 - 30.3%) for EHEC O157 and 2.1% (1.0 - 4.9%) for non-O157 EHEC. However, 756 
there were no significant differences in the prevalence of EHEC O157 (P = 0.71) and non-O157 757 
EHEC (P = 0.56) between study areas. 758 
 759 
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 Evaluation of pen- and feedlot-level risk factors  760 
Pen-level variables significantly associated with the within-pen prevalence estimates of 761 
EHEC (EHEC O157 and non-O157 EHEC [all non-O157 grouped]) based on univariable 762 
analyses (P < 0.20) included sampling month, size of the pen, and sex composition of the pen for 763 
EHEC O157, and sampling month and sex composition of the pen for the non-EHEC O157 764 
outcome (Table 4).  Only sampling month remained significantly associated (P < 0.01) with the 765 
within-pen prevalence of EHEC O157 in the final model.  Cumulative model-adjusted within-766 
pen prevalence estimates (95% confidence intervals) for EHEC O157 were 35.4% (22.1 - 51.4%) 767 
for June, 11.4% (6.3 - 19.8%) for July, and 18.6% (10.7 - 30.4%) for August, with significant 768 
within-pen prevalence differences between June and July (P < 0.01), June and August (P < 0.01), 769 
and July and August (P < 0.01).  Sampling month (P < 0.01) and sex composition of the pen (P = 770 
0.02) were significantly associated with the within-pen prevalence of non-O157 EHEC.  Model-771 
adjusted within-pen prevalence estimates (95% confidence intervals) for non-O157 EHEC were 772 
2.8% (1.1 - 7.1%) for June, 1.5% (0.6 - 3.7%) for July, and 0.6% (0.1 - 1.8%) for August, with 773 
significant within-pen prevalence differences between June and July (P = 0.03), June and August 774 
(P < 0.01), and July and August (P = 0.04).  Model-adjusted within-pen prevalence estimates 775 
(95% confidence intervals) for non-O157 EHEC were 1.1% (0.3 - 3.8%) for heifer-based pens, 776 
3.1% (1.3 - 7.1%) for steer-based pens, and 0.5% (0.2 - 2.8%) for mixed pens (i.e., both steers 777 
and heifers), with significant within-pen prevalence differences between steer and mixed pens (P 778 
= 0.02).   779 
With non-O157 EHEC, separate models were fitted for EHEC O103 and O145. Model-780 
adjusted mean within-pen prevalence varied significantly by month for EHEC O103 (P = 0.03) 781 
and EHEC O145 (P < 0.01).  Within-pen prevalence estimates (95% confidence intervals) for 782 
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EHEC O103 were 0.1% (0.0 - 1.7%) for June, 2.1% (1.0 - 4.4%) for July, and 2.4% (1.1 - 5.4%) 783 
for August, with significant within-pen prevalence differences between June and August (P = 784 
0.01) and between July and August (P = 0.02).  Within-pen prevalence estimates (95% 785 
confidence intervals) for EHEC O145 were 1.5% (0.0 - 4.7%) for June, 0.2% (0.0 - 1.0%) for 786 
July, and 0.2% (0.0 - 1.6%) for August, with a significant difference in within-pen prevalence 787 
between June and July (P < 0.01).   788 
None of the feedlot-level demographic or management variables (direct-fed microbial, 789 
distiller’s percentage, feedlot capacity, and manure management) were significantly associated 790 
with the cumulative within-pen prevalence of EHEC O157 and non-O157 EHEC by feedlot in a 791 
univariable analyses (all P values > 0.20).  792 
 793 
 Intraclass correlation coefficient 794 
 The intraclass correlation coefficient (ICCs) describing the correlation between fecal 795 
samples within pens for EHEC O157 was 0.26, and was 0.31for non-O157 EHEC, indicating that 796 
most of the variability occurred between pens rather than within pens. The ICCs for EHEC O157 797 
(0.08) and non-O157 EHEC (0.04) for samples within feedlots indicate that most of the 798 
variability occurred within rather than between feedlots.  Intraclass correlation coefficients for 799 
individual non-O157 EHEC serogroups (O26, O103, O111, O121, and O145) were not computed 800 
due to lack of model convergence. 801 
 802 
 Discussion 803 
 Our findings provide insight into the regional-, feedlot-, and pen-level differences of 804 
EHEC-7 shedding in cattle feces, which enhances our knowledge of the epidemiology and 805 
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distribution of EHEC and provides a better understanding of the level at which pre-harvest 806 
interventions could be effective. By lowering the pathogen load prior to harvest, transmission 807 
along the contamination pathway (i.e., fecal to hide to carcass pathway) may be mitigated.  In the 808 
present study, all study feedlots had at least one sample positive for EHEC O157 and non-O157. 809 
Furthermore, approximately 31% of the study pens had one or more fecal samples that tested 810 
positive for non-O157 EHEC, whereas 62% of pens tested positive for EHEC O157. Although 811 
multiple studies have reported non-O157 EHEC fecal prevalence estimates in cattle 812 
(Cernicchiaro et al., 2013; Baltasar et al., 2014; Ekiri et al., 2014; Paddock et al., 2014; 813 
Dewsbury et al., 2015), the current study provides the most comprehensive assessment of 814 
feedlot- and pen-level prevalence of EHEC-7 serogroups in feces of commercial feedlot cattle, 815 
prior to harvest, from several feedlots in two main U.S. cattle feeding areas. 816 
Although there slight difference between demographic and management characteristics of 817 
study feedlot operations, we believe these operations are fairly representative of the other 818 
commercial feedlot operations in the region.  The low prevalence of non-O157 EHEC found in 819 
our study pens is consistent with findings from recent reports on summer-fed commercial feedlot 820 
cattle, despite key differences in diagnostic methods, case definitions, and study populations 821 
(Cernicchiaro et al., 2013; Dargatz et al., 2013; Baltasar et al., 2014; Ekiri et al., 2014; Dewsbury 822 
et al., 2015).  To date, the published literature has indicated well-established diagnostic methods 823 
for detection of EHEC O157 (Osmisakin et al., 2003; LeJeune et al., 2006; Fox et al., 2008); 824 
however, given the lack of a reference method of detection for non-O157 EHEC, several 825 
detection methods are used which makes the comparison of prevalence estimates across studies 826 
challenging (Bettelheim, 2007; Cernicchiaro et al., 2013; Baltasar et al., 2014; Ekiri et al., 2014; 827 
Dewsbury et al., 2015; Noll et al., 2016).  In the current study we used pooled IMS beads for 828 
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non-O157 EHEC serogroup detection.  As reported by Noll et al. (2016), pooling IMS beads 829 
resulted in higher throughput of samples, and a less labor-intensive procedure which has shown 830 
to have similar detection capabilities than single IMS bead procedures.   831 
To our knowledge, there are few studies that have reported prevalence estimates for 832 
EHEC-7 from several commercial feedlot operations in the United States.  The current study 833 
demonstrated that the overall frequency of detection of non-O157 EHEC was three times lower 834 
than EHEC O157 among pens.  Moreover, as also seen in previous studies (Cernicchiaro et al., 835 
2013; Dargatz et al., 2013; Baltasar et al., 2014; Ekiri et al., 2014; Dewsbury et al., 2015), 836 
prevalence varied greatly between pens in all study feedlots for both non-O157 EHEC and 837 
EHEC O157.  Although the Dargatz et al., (2013) multi-feedlot (n = 21) and multi-state (n = 4) 838 
study reported fecal prevalence of EHEC-7, prevalence was based on pooled samples from up to 839 
40 animals prior to PCR-only confirmation. In our study, we utilized individual fecal pats that 840 
were later confirmed for the presence of EHEC-7 by both culture and PCR methods.  841 
Despite the fact that multiple risk factors for STEC O157 prevalence have been identified 842 
in commercial feedlot cattle (Sargeant et al., 2004; Renter et al., 2005; Rangel et al., 2005; Smith 843 
et al., 2005; Fox et al., 2008; Callaway et al., 2014; Smith, 2014), associations between  those 844 
risk factors with non-O157 STEC prevalence have not been yet demonstrated (Smith, 2014).  In 845 
the current study, significant differences in fecal prevalence between June, July, and August 846 
were identified for EHEC O157, all non-O157 EHEC, EHEC O103 and EHEC O145.  Although 847 
variation in prevalence of STEC O157 has been reported in weeks within a season (Renter et al., 848 
2005; Smith et al., 2005), the reason behind this phenomenon is still unknown.  The temporal 849 
effects of EHEC shedding in cattle cohorts may be due to animal housing, pen condition, 850 
precipitation, and temperature at time of sample collection.  Additionally, our study found 851 
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significant differences in the overall non-O157 EHEC prevalence based on the sex composition 852 
of the study pens.  Potential environmental disturbances (e.g., stress, behavioral dynamics, 853 
dietary differences) affecting cattle in pens of mixed sex composition may modify conditions of 854 
their lower gastrointestinal tract allowing non-O157 EHEC to out-compete other organisms.  In 855 
contrast, feedlot management factors were not significantly associated with the prevalence of 856 
EHEC-7 serogroups, likely due to either the small number of feedlots sampled (n = 8) or perhaps 857 
because most of the variability occurred within versus between feedlots which prevented us to 858 
detect significant differences.   859 
Variance components indicated a higher variability between than within pens for both 860 
fecal prevalence of non-O157 EHEC and EHEC O157; for feedlots, the variability was higher 861 
within than between feedlots.   Hence, pre-harvest interventions targeted at the pen-level would 862 
likely have higher impact on EHEC-7 fecal shedding compared to those targeted at the feedlot-863 
level.  Although Sargeant et al. (2004) reported similar results for pen and feedlot of STEC 864 
O157, the effects of non-O157 STEC have not been reported.  865 
We found a widespread distribution of EHEC-7 in feces from cohorts of finishing cattle 866 
fed during the summer months, with EHEC O157, O103, and O145 being the serogroups most 867 
frequently detected in this study population.  Further, sampling month and sex composition of 868 
the pen were identified as potential risk factors for non-O157 EHEC and EHEC O157.  Thus, the 869 
potential combination of pre-harvest interventions and pen-level management strategies may 870 
have positive food safety impacts.  Moreover, data on pre-harvest fecal prevalence at different 871 
hierarchical levels provide necessary estimates to input into quantitative risk assessment models 872 
to assess potential human risks associated with EHEC-7 along the beef chain. 873 
 874 
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Table 4.1 Demographic and management characteristics of study feedlots operation.  979 
 980 
1 Type of Fed cattle: Dairy = Holstein, Beef = Cross-bred cattle, or Both = Dairy and Beef 981 
2 Manure storage: on site (pen-floor fecal material stored at the feedlot) and off site (pen-floor fecal material is not stored at the 982 
feedlot)  983 
3 Cattle were fed a direct fed microbial (DFM) product as reported by the feedlot manager at each visit: Yes (animals received a DFM 984 
product) and No (indicates no DFM was fed)985 
 Study Area A Study Area B  
 Feedlots Feedlots 
Variable, units 1 2 3 4 A B C D 
Feedlot capacity, animals 50,000 25,000 50,000 11,500 85,000 12,000 8,000 14,000 
Average pen size (range), 
animals 
179.7   
(68-234) 
134.9   
(55-283) 
184.9   
(98-279) 
66.4     
(30-113) 
341.1 
(235-582) 
56.2     
(39-119) 
196.7   
(50-297) 
142.8   
(60-225) 
Average days on feed 
(range), days 
319.1 
(283-368) 
278.1 
(146-364) 
151.8    
(94-230) 
174.7 
(135-279) 
55.2      
(28-110) 
317.4 
(116-382) 
68.1     
(11-157) 
125.1   
(79-179) 
Type of cattle1 Dairy Beef Beef Both Beef Both Beef Beef 
Manure Storage2 On site Off site On site On site Off site On site Off site On site 
Ration percentage of 
distillers, % 
10-30 <10 10-30 10-30 10-30 >30 10-30 >30 
Fed DFM product3 No Yes No Yes  Yes Yes Yes Yes 
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Table 4.2 Cumulative sample-, pen-, and feedlot-level percent positive of EHEC O26, O45, O103, O111, O121, O145, and 986 
O157, per study area1 and overall  987 
  EHEC positives, n (%) 
 Sample-level2 Pen-level3 Feedlot-level4 
EHEC 
Study Area A 
(n=926) 
Study Area B 
(n=960) 
Overall 
(n=1,886) 
Study Area A 
(n=62) 
Study Area B 
(n=64) 
Overall 
(n=126) 
Study Area A 
(n=4) 
Study Area B 
(n=4) 
Overall 
(n=8) 
O26   1 (0.1)   3 (0.3)   4 (0.2)   1 (1.6)   2 (3.1) 3 (2.4) 1 (25.0) 1 (25.0) 2 (25.0) 
O45   0 (0.0)   4 (0.4)   4 (0.2)   0 (0.0)   4 (6.3) 4 (3.2)      0 (0.0) 2 (50.0) 2 (25.0) 
O103 26 (2.8) 12 (1.3) 38 (2.0)  12 (19.4)  11 (17.2) 23 (18.3)    4 (100.0)   4 (100.0)   8 (100.0) 
O111   4 (0.4)   2 (0.2)   6 (0.3)   1 (1.6)   1 (1.6) 2 (1.6) 1 (25.0) 1 (25.0) 2 (25.0) 
O121   0 (0.0)   0 (0.0)   0 (0.0)   0 (0.0)   0 (0.0) 0 (0.0)      0 (0.0)      0 (0.0)    0 (0.0) 
O145   3 (0.3)   8 (0.8) 11 (0.6)   3 (4.8)   4 (6.3) 7 (5.6) 3 (75.0) 2 (50.0) 5 (62.5) 
          
 Sample-level2 Pen-level3 Feedlot-level4 
EHEC 
Study Area A 
(n=683) 
Study Area B 
(n=710) 
Overall 
(n=1,393) 
Study Area A 
(n=61) 
Study Area B 
(n=64) 
Overall 
(n=125) 
Study Area A 
(n=4) 
Study Area B 
(n=4) 
Overall 
(n=8) 
O157 117 (17.1) 143 (20.1) 260 (18.7) 33 (54.1) 45 (70.3) 78 (62.4) 4 (100.0) 4 (100.0) 8 (100.0) 
 988 
1 Study Area A comprised 4 feedlots in a 150-mile area in northwest Texas and Study Area B comprised 4 feedlots in a 100-mile area 989 
in central Nebraska 990 
2 Cumulative sample-level percent positives was calculated as the number of samples that tested positive for each EHEC, divided by   991 
the total number of samples tested  992 
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3 Cumulative pen-level percent positives was calculated as the number of pens that had at least one positive sample for each EHEC, 993 
divided by the total number of pens sampled  994 
4 Cumulative feedlot-level percent positives was calculated as the number of feedlots that had at least one positive sample for each 995 
EHEC, divided by the total number of study feedlots  996 
 106 
 
Figure 4.1 Cumulative model-adjusted1 within-pen prevalence estimates of EHEC O26, 997 
O45, O103, O111, O121, O145, and O157 in cattle feces.  Error bars indicate the upper 998 
limit of the 95% confidence interval of model-adjusted prevalence mean estimates. 999 
 1000 
 1001 
1 From generalized linear mixed models using a binomial distribution, logit link and random 1002 
intercepts for sampling week and feedlot within study area1003 
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Table 4.3 Model-adjusted mean within-pen prevalence of EHEC O26, O45, O103, O111, O121, O145, and O157 in cattle feces, 
by feedlot operation and study area 
 
 EHEC Prevalence, % (SEM)1 
 Study Area A Study Area B 
 Feedlots Feedlots 
EHEC 1 2 3 4 A B C D 
O26 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.4 (0.4) 0.0 (0.0) 0.0 (0.0) 1.3 (0.7) 0.0 (0.0) 
O45 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.3 (0.7) 0.4 (0.4) 
O103 4.5 (3.0) 1.1 (0.9) 1.7 (1.3) 1.6 (1.3) 0.4 (0.5) 0.3 (0.3) 1.6 (1.3) 2.0 (1.5) 
O111 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.7 (0.8) 0.0 (0.0) 0.0 (0.0) 0.8 (0.6) 0.0 (0.0) 
O121 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 
O145 0.0 (0.0) 0.5 (0.5) 0.4 (0.4) 0.4 (0.4) 0.0 (0.0) 0.0 (0.0) 1.3 (0.7) 2.1 (0.9) 
O157   10.1 (5.0) 7.7 (4.4) 25.8 (10.0)   23.5 (9.5)   15.8 (7.1)   25.6 (9.9) 5.4 (3.2) 39.1 (12.5) 
 
1 From generalized linear mixed models using a binomial distribution, logit link, fixed effect for feedlot and random effect for 
sampling week,  
SEM: Standard error of the mean  
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Table 4.4 Cumulative model-adjusted1 mean within-pen fecal prevalence estimates of EHEC O157 and non-O157 EHEC for 
pen-level demographic variables tested in univariable models  
 EHEC O157   Non-O157 EHEC  
Variable Prevalence % (95% CI) P-value  Prevalence % (95% CI) P-value 
Sampling month2  < 0.01   < 0.01 
    June   35.4 (22.1-51.4)    5.0 (2.2-10.8)  
    July 11.4 (6.3-19.8)   2.8 (1.3-6.1)  
    August   18.6 (10.7-30.4)   1.1 (0.4-2.8)  
Sex composition of pen3  0.11   < 0.01 
    Heifer 13.6 (6.4-26.6)   0.7 (0.1-3.1)  
    Steer 17.0 (9.0-29.7)   2.9 (1.0-8.2)  
    Mixed   23.3 (11.8-40.7)   0.5 (0.1-2.3)  
Pen Size (animals/pen)4  0.07  - - 
    < 100  14.5 (7.3-26.7)     
    100-200   22.2 (12.1-37.0)     
    > 200-300 15.2 (7.9-27.4)     
    > 300 19.3 (7.5-41.3)     
1 From generalized linear mixed models (GLMM) using a binomial distribution and logit link  
2 GLMM included a fixed effect for month and a random intercept for feedlot within study area  
3 GLMM included a fixed effect for sex composition of the pen and random intercepts for sampling week and feedlot within study 
area 
4 GLMM included a fixed effect for pen size and random intercepts for sampling week and feedlot within study area 
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Chapter 5 - Conclusions 
 
Several conclusions on the epidemiology of Shiga toxin-producing Escherichia coli 
serogroups (O26, O45, O103, O111, O121, O145, and O157; STEC-7) in commercial feedlot 
cattle can be made based on the literature review and the subsequent research described within 
this dissertation.  Previous research has focused more on the epidemiology of STEC O157 than 
non-O157 STEC in commercial feedlot cattle, yet both pose a public health risk due to the 
potential transmission along the fecal to hide to carcass pathway.  Further, understanding and 
mitigation of this transmission pathway requires knowledge of both the STEC concentration and 
prevalence at the time and place of sampling along this pathway.  In general, post-harvest 
interventions seem to be effective at reducing STEC-7 from plant entry to final product, yet 
previous research suggests that pre-harvest interventions for STEC O157 could be important in 
reducing the pathogen load prior to harvest.  In addition, data regarding the effectiveness of pre-
harvest interventions against fecal shedding of STEC-7 and subsequent performance impacts 
required additional evaluation in commercial feedlot operations.  Review of the literature 
indicates that additional cattle studies are needed to develop a better understanding of the 
epidemiology of STEC-7 and evaluate potential risk factors associated with shedding of STEC-7 
in cattle feces.   
We used two distinct study designs to evaluate the impact of commercially available pre-
harvest interventions and develop a better understanding of the epidemiology of STEC-7 in 
commercial feedlot cattle.  The first study design was an experimental randomized pen-level 
field trail in a large commercial feedlot, which allowed us to evaluate the efficacy of pre-harvest 
interventions against fecal shedding of STEC O157 (first study in this dissertation) and quantify 
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the corresponding impacts of pre-harvest interventions on cattle performance (second study in 
this dissertation was a continuum of the efficacy study).  Overall, we indicated that there were no 
significant interactions between the commercially available vaccine (SRP® vaccine) and the 
direct-fed microbial (DFM; Bovamine®) in either study.  This is important because it indicates 
that beef producers (or their clients) can’t expect added benefits of using both products.  
However, we believe that we were the first to demonstrate that the two dose regimen of the SRP 
vaccine reduced fecal prevalence of STEC O157 and prevalence of high shedders, but negatively 
impacted performance (e.g., dry matter intake and weight gain) when compared to non-
vaccinated pens (e.g., cattle were not re-handled or given a placebo).  The low dose DFM had no 
effect on fecal prevalence of STEC O157 and prevalence of high shedders, but positively 
impacted performance (e.g., increased total gain and gain to feed ratio).  Although these 
commercially available products, SRP® vaccine and Bovamine®, indicated differential effects for 
efficacy and cattle performance, these results should provide practical information for end-users 
(e.g. feedlot and packing plant operators) to utilize prior to making operational decisions for pre-
harvest implementation.  Yet, our work was built upon the idea that pre-harvest interventions 
may not only complement post-harvest interventions, but further decrease the public health 
concerns and costly beef recalls by reducing the overall STEC O157 fecal load prior to plant 
entry.  However, we understand that the ecology and epidemiology of STEC O157 in cattle is 
complex and additional information is warranted, due to the multiple risk factors impacting the 
transmission, environmental survival, and widespread shedding differences among cattle, pens, 
feedlots, and regions.  Additionally, continual education, research and surveillance are required 
to enhance our knowledge, detection, and reduction methods of STEC O157. However, the beef 
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industry has the opportunity to strive to reduce human illnesses and beef recalls caused by these 
foodborne pathogens through pre-harvest interventions. 
The second study design was an observational cross-sectional study that occurred in eight 
commercial feedlot operations from two distinct cattle feeding areas (e.g., Texas and Nebraska) 
during the summer months.  In this study, we reported a widespread distribution of EHEC-7 in 
cattle feces, with EHEC O157, O103, and O145 being the serogroups most frequently detected in 
this study population.  Although EHEC O157 was much more frequently detected, both EHEC 
O157 and non-O157 EHEC were present in all feedlot operations.  Fecal shedding of EHEC 
O157 and non-O157 EHEC varied over-time, but there was no evidence for a difference between 
study areas.  In addition, fecal shedding was not associated with feedlot-level management 
factors. However, we found that most of the variability in prevalence occurred at the pen-level.  
Thus, the potential combination of pre-harvest interventions and management strategies applied 
at the pen-level may have the greatest potential impacts on EHEC in the beef chain.  Moreover, 
our findings provide insight into the regional-, feedlot-, and pen-level differences of EHEC-7 
shedding in cattle feces, which enhances our knowledge of the epidemiology and distribution of 
EHEC and provides a better understanding of the level at which pre-harvest interventions could 
be effective.  By lowering the pathogen load prior to harvest, transmission along the fecal to hide 
to carcass pathway could be mitigated.  However, additional studies are required to further 
evaluate the relationship of fecal prevalence with hide contamination and subsequent carcass 
contamination at the cohort levels.  Further, the ability to identify risk factors as potential control 
points may enable the ability to positively impact public health concerns and food safety by 
reducing the fecal load in the feedlot production environment.   
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Overall, the research described in this dissertation provides an assessment of the efficacy 
and production impacts of commercially available pre-harvest interventions and provides multi-
level prevalence estimates of STEC-7 in commercial feedlot operations.  Previous research 
indicates that pre-harvest interventions for STEC O157 may have the ability to complement post-
harvest interventions and decrease the risk of STEC transfer to beef at harvest; however, there 
are limited data illustrating the impact of a single pre-harvest intervention or the combination of 
pre-harvest interventions on STEC-7 prevalence at each step (e.g., fecal shedding, hide 
contamination, carcass contamination, and beef at the grocery store) along the beef production 
system.  Although there is a growing body of literature for pre-harvest interventions, additional 
data is required for several of these interventions to determine the efficacy of these products in 
commercial feedlot operations with different attributes, including differences in biosecurity, 
cattle source, cattle handling practice, diet, geographic location, and season.  Data regarding the 
concentration, prevalence, and transmission of STEC-7 within cohorts of cattle are necessary to 
improve the knowledge on the epidemiology of STEC-7.  Finally, there is a need for a more 
comprehensive understanding of the economic impacts of implementing pre-harvest 
interventions in commercial feedlot operations, as there are currently no well-defined 
mechanisms (e.g., government policies, cattle marketing incentives, and/or consumer demands) 
to mitigate the cattle producers financial burden associated with implementing pre-harvest 
interventions. 
